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Abstract 
The Effect of Regulatory T Cells on an Age-altered Specific CD8 T Cell Response 
Following Influenza Infection 
Yolanda Williams-Bey, BS 
Donna Murasko, PhD 
 
The elderly population is a major user of our health care resources. With this 
population of people growing faster than any other age group, it is important to find ways 
to reduce the increasingly high morbidity and mortality rates due to infections. 
Several studies have demonstrated that both aged mice and humans have a 
reduced CD8 T cell response to influenza infection. Further, it has been demonstrated 
that these alterations result from both intrinsic and extrinsic factors. Recently, it has been 
observed that there is an increase in the regulatory T cells (Treg cell) percentage in aged 
mice. No study has evaluated if this increase in Treg cells could be an extrinsic factor 
which suppresses the expansion and function of CD8 T cell responses during acute 
influenza infection. Therefore, we hypothesized that a major contributor to the extrinsic 
changes that effect T cell responses in aged mice are Treg cells. 
We compared the phenotype and function of Treg cells from aged and young 
mice. Interestingly in vitro depletion of Treg cells had no effect on CD8 T cell responses 
in young or aged mice. Further there appears to be no significant differences in the ability 
of Treg cells from aged mice to suppress specific CD8 T cells isolated from TCR 
transgenic (Tg) mice compared to Treg cells isolated from young mice.  
Although we found no differences in the function of Treg cells of aged compared 
to young mice in vitro, this does not mean that Treg cells do not demonstrate an age-
  xi 
associated differential impact in vivo following influenza infection. To evaluate the 
potential impact of Treg cells of aged mice on CD8 T cell expansion and function we 
studied the kinetics of Treg cells following influenza infection of young and aged mice. 
Following influenza infection Treg cells expand in aged but not young mice. Further the 
peak of CD8 T cell expansion and IFN-γ production in aged mice coincides with 
contraction of expanded Treg cell percentage and activation. We believe that this 
increased expansion early during infection in aged mice interferes with CD8 T cell 
expansion and function.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  xii 
 
 
 
 
 
 
 
  
1 
Chapter One:  Introduction 
 
1.1 Aging Immunity  
It has been reported in both humans and rodents that aging coincides with a 
reduced ability to respond to infectious diseases. Individuals over the age of 65 
demonstrate increased incidences of infection, cancer, autoimmunity and 
neurodegenerative disorders (1-3). These individuals also have increased morbidity and 
mortality during infection and disease (4). Thompson et al. reported that during influenza 
season individuals over the age of 65 had increased rates of hospitalization and death 
from primary influenza infection (5). While vaccination has been shown to enhance 
antiviral responses, elderly patients demonstrate a reduced response to influenza 
vaccination compared to younger adults (6). The reduced response to infection has also 
been demonstrated in other viral models, as well as bacterial and parasitic infections (4, 
7, 8).  
The age-associated changes in immunity are believed to be due to an overall 
dysregulation of the immune response. Changes in the inducible response have been 
documented in both innate and adaptive immunity. In addition these changes appear to be 
a result of intrinsic factors within the cell as well as extrinsic factors that change the 
conditions and environment in which immune cells function (9, 10).  Although there are 
noticeable changes in innate immunity, these changes are only beginning to be studied. 
The most extensive studies on immunosenescence demonstrate that the most consistent 
changes seen in aging are within the T cell compartment (11).   
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1.1.1 Innate Immunity and Aging 
Macrophages and dendritic cells (DCs) are innate cells involved in anti-viral 
immunity and have been shown to have an effect on T cell responses (12). Inconsistent 
changes have been reported in the function of macrophages isolated from aged mice 
compared to young mice. These differences appear to be the result of the tissues from 
which macrophages are isolated and the stimuli used to study the response (13). These 
discrepancies among studies extend to the cytokine profile secreted by macrophages of 
aged compared to young mice in responses to stimulation (13, 14). Although many 
parameters of macrophage function continue to be debated, IFN-γ activation of 
macrophages is consistently reduced in aged mice during infection (15-17).  
A major function of cells involved in innate immunity is the presentation of 
antigen from invading pathogens to T cells. While macrophages are a key player in 
antigen presentation, DCs are considered to be the most potent at this function. DCs are 
regarded as professional antigen presenting cells (APCs) (18). Age-altered differences in 
the function of DCs have been shown to be dependent on the experimental design, 
specifically results from in vitro experiments demonstrate no reduction in the function of 
enriched DCs isolated from aged mice (19, 20), while studies performed using total 
splenocytes isolated from aged mice demonstrate reduced priming of CD8 T cells (19). 
Paula et al. reported that DC maturation is reduced in DCs isolated from the bone marrow 
of aged mice compared to young mice. This inability of DC maturation is probably a 
result of extrinsic factors in the aged environment. Several studies have demonstrated that 
immature DCs (iDCs) are efficient at inducing the development and function of 
regulatory T cells (Treg cells) through the secretion of IL-10 (21). The inability of the 
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aged environment to support the growth of iDCs to become mature DCs promotes the 
enhancement of tolergenic responses while interfering with CD8 T cell response. Jiang et 
al. also hypothesize that the decreased ability of APCs in total splenocytes of aged mice 
to prime CD8 T cells may be a result of the aged environment (19).  
In response to most viral infections DCs secrete Type I IFN-α/β (22). Type I IFN-
α/β is a potent stimulator of the immune response leading to the production of other anti-
viral cytokines and effector T cell function. All nucleated cells in the body can both 
respond to and produce Type I IFN-α/β;  however DCs, specifically plasmacytoid DCs 
(pDC), are the biggest producer of Type I IFN-α/β during infection (23). We have 
demonstrated that the function of type I IFN-α/β is significantly reduced in aged mice 
following influenza infection (Figure 1.1). It has been reported that clearance of herpes 
simplex virus-2 (HSV-2) infection in aged mice is reduced due to decreased ability of 
DCs to produce type I interferon (IFN-α/β) (9, 24).  
 
 
 
Figure 1.1 Functional Type I IFN-α/β following influenza infection in young and aged 
C57BL/6 mice. Young and aged mice were infected iv with 300 H.A.U. PR8 influenza 
virus and units of type I IFN in the serum 24 hours after infection, were determined using 
a bioassay. N=3 each age group, representative of 2 experiments. ** = p<0.01. 
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NK cells are a first line of defense during infection and tumor immunity. NK cells 
are important in killing cells that are infected by foreign pathogen or tumor cells prior to 
the activation of an antigen specific immune response. NK cell expansion and 
cytotoxicity is reduced in aged mice following infection (25).  
Collectively changes in macrophage and DC function seen in aging may be the 
extrinsic factors that have a negative effect on T cell responses which are required for 
successful clearance of viral infection. Although macrophages and DCs directly control 
infection in innate immunity, these cells promote an adaptive immune response following 
infection by both the secretion of pro-inflammatory cytokines and antigen presentation 
(26, 27).  
 
1.1.2 Adaptive Immunity and aging 
Age-associated changes in innate immunity should not be overlooked, not only 
because an innate response is absolutely necessary to control infection, but also because it 
supports the induction of a robust adaptive immune response (28). A hallmark of the 
adaptive immune response is diversity. Specifically, the immune system produces B and 
T cells with a diverse repertoire (naïve cells), which respond to antigen being presented 
to them by antigen presenting cells (APC’s). In addition there is a pool of antigen-
experienced cells (memory cells) which can respond more quickly to the antigen they 
recognize. Aged mice and humans demonstrate an age-altered decrease in both the 
primary immune response and memory response (29). A reduction in the diversity of both 
the B cell receptor (BCR) and T cell receptor (TCR) diversity has been reported in aged 
mice (30, 31). This decrease in diversity has a negative impact on the aged immune 
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response to infection (32). In addition to the reduced diversity seen with aging, the 
lymphocyte population of aged mice demonstrates an increased percentage of memory 
cells and a decreased pool of naïve cells (33, 34).  
One age-associated change that impacts T cell responses is thymic involution. 
Thymic involution results in a decreased naïve T cell pool (34). Significant thymic 
involution is said to begin at puberty, however T cells are still being produced until 
approximately 60 years of age in humans and 24 months in B6 mice, with these numbers 
varying depending on genetic background (34, 35).  
Similar to T cells, the reduced diversity seen in B cells may result from the 
reduced ability of the bone marrow to produce B cell precursors. The bone marrow is 
instrumental in producing not only B cells but all other lymphoid cells as well. Linton et 
al. propose that the decrease in naïve B cells may be due to decreased proliferation and 
survival of cells, rather than a decreased ability for B cell production by the bone marrow 
(35).  
Type I IFN-α/β enhances the function of B cells, increasing the production of 
antibodies (Ab)(36). B cells protect the intracellular space from foreign pathogens by 
secreting antibodies following primary infection, which bind and target pathogen for 
removal from the body. Although the number of B cell precursors is reduced in aging, 
there is no reduction in circulating B cells in the periphery. While the number of B cells 
in the periphery remains unchanged with aging, the function of these cells is decreased as 
shown by reduced antibody titers, antibody affinity, immunoglobulin switching and the 
ability to proliferate in response to LPS stimulation in vitro (29, 37). Although antibody 
response to foreign antigen is reduced in aged mice, it has been reported by several 
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studies that aged mice produce increased levels of auto-antibodies which are specific for 
self-antigen (38, 39). Bovbjerb et al. proposed that this increased ability to produce 
autoantibody in response to self-antigen both in vitro and in vivo, while producing low 
titers and affinity of conventional antibodies, demonstrate that the reduced humoral 
response in aged mice may be the result of alterations in the regulatory component of the 
immune response and not dysfunctional immune cells (38).   
While age-altered changes in the humoral response to infection have been 
demonstrated, many of these studies have shown that the changes in antibody are 
dependent on T cell responses. It has been proposed that the effectiveness of CD4 T cells 
in aged mice to form synapses with APCs and produce sufficient levels of pro-
inflammatory cytokines to induce B cells to activate and produce antibodies is reduced 
during response to infection (40).  Maue et al. demonstrated that the addition of adjuvant, 
which increases the activity of CD4 T cells in aged mice, also resulted in increased 
production of B cell differentiation and antibody production (41).   
The importance of a T cell response to control infection has been demonstrated by 
depletion of T cells resulting in the continued presence of virus. It is believed by some 
that antibodies protect extracellular spaces, while T cell immunity is required for 
intracellular pathogens such as influenza virus (42). Further cell-mediated responses by T 
cells have been demonstrated to make significant contributions to other arms of immunity 
both humoral and innate, specifically cytoxicity of infected cells lead to enhanced 
infiltration of macrophages and the secretion of pro-inflammatory cytokines that enhance 
helper T cell function (41, 43).  
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It has been shown that during aging there is a decrease in the TCR variant beta 
(Vβ) chain, which reduces the number of TCR from approximately 108 to 106. In addition 
its been determined that a decrease in TCR diversity significantly decreases the T cell-
mediated immune response (44). Yager et al. argues that the reduced TCR repertoire 
diversity leads to a reduced ability of aged mice to respond to primary infection. In this 
report aged B6 mice have a reduced number of T cells which could respond to influenza 
epitopes NP and PA (31). It has been demonstrated that this decline in diversity affects 
both CD4 and CD8 T cells reducing both the helper T cell response as well as the 
cytotoxic T cell response (32).  
CD4 T cells differentiate into several subsets of T cells: 1) Th1 cells which have 
been shown to be involved in the cell-mediated response; 2) Th2 cells which secrete pro-
inflammatory cytokines that enhance the humoral immune response leading to Ab 
production; 3) the newly defined Th17 cells, which, while not well understood, are 
thought to be involved in host defense against specific pathogens and may play a role in 
autoimmunity (45); and 4) regulatory T cells which have been have been shown to 
protect the host from autoimmunity and reduced tissue destruction following an immune 
response (46).  
T cells from aged mice have a reduced capacity to activate and expand in 
response to mitogenic stimulation when compared to T cells isolated from their younger 
counterparts. These differences were cited in both CD4 and CD8 T cell compartments 
(47). 
CD4 T cells have been shown to have intrinsic defects in the signaling pathways 
that are involved in TCR recognition and T cell activation (40, 48). Several studies have 
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demonstrated that some of these intrinsic alterations could actually be a result of the 
environment. In these studies Miller and colleagues demonstrated that CD4 TCRs interact 
weakly with APCs (49).  This reduced interaction between APC and CD4 T cells leads a 
decrease activation of downstream events in aged mice. One of the major changes 
demonstrated in CD4 T cells from aged mice is their inability to expand as well as those 
from young mice. This decreased proliferation of aged T cells reduces the number of 
expanded CD4 helper T cells, as well as the level of cytokines being produced, resulting 
in a reduced ability to help other lymphocyte populations. A major cytokine secreted by 
CD4 T cells is IL-2. Haynes et al. demonstrated that following stimulation of T cells with 
allogeneic antigen, CD4 T cells from aged mice proliferate poorly and secrete 
significantly lower amounts of IL-2. However addition of IL-2 significantly enhanced the 
proliferation of CD4 T cells of aged mice in this system (50). Further Elrefaei et al. 
demonstrated that during acute E55+MuLV infection aged mice produced significantly 
lower amounts of IL-2, and that this decrease was associated with fewer cells producing 
IL-2 in aged mice following in vivo infection (51).  
T cell differentiation has been reported to change with age in both rodents and 
humans during infection (40, 52). Following immune activation, CD4 T cells have the 
ability to differentiate into several subsets. Many studies have shown that in a Th1 
effector T cell function IFN-γ is secreted, whereas Th2 responses results in the 
production of IL-4. Aged mice and humans more readily differientiate into Th2 CD4 T 
cells, as assessed by the production of IL-4. Studies demonstrated an increased 
involvement of Th2 responses in aging immunity and an overall reduced ability for CD4 
helper T cells to differentiate into their respective subsets (40, 52, 53). Huang et al. 
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demonstrated that although Th1 and Th2 differentiation appears to be changed in aged 
mice, CD4 T cells from aged readily differentiate into Th17 cells following in vitro 
stimulation with anti-CD3 and anti-CD28 mAb (54). It is generally accepted that Treg 
cell percentage in aged mice is also increased.  
The importance of CD8 T cell function during an immune response can be 
demonstrated by reduced function and infiltration of several APCs, when CD8 T cells are 
absence or functioning at reduced levels. Specifically it has been demonstrated that 
macrophage function can be influenced by the cytotoxic response of CD8 T cells in 
inflammation, since during inflammation infiltration of CD8 T cells precedes 
macrophage accumulation and depletion of CD8 T cells reduces macrophage function 
(55, 56). It has also been demonstrated that in the absence of CD8 T cells, viral clearance 
is abrogated (57). Clonal expansion of cells specific for antigen is important during an 
immune response (58). Clonal expansion of CD8 T cells has been demonstrated to be 
reduced in aged mice (40). Jiang et al. reported that CD8 T cells from aged mice had a 
delayed response to in vitro stimulation with mitogen and also that these cells have 
reduced rounds of proliferation (47).  
It has been demonstrated that some of the changes that occur in CD8 T cells in 
aged mice are a result of the environment. CD8 T cell activation and expansion relies on 
sufficient antigen presentation by APCs. Plowden et al. demonstrated that APCs from 
aged mice were ineffective at stimulating CD8 T cells (59). Specifically their studies 
report that when CD8 T cells from aged mice were stimulated in the presence of young 
macrophages they responded well, whereas stimulation of young CD8 T cells with aged 
macrophages resulted in reduced expansion and IFN-γ production. In addition antigen 
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presentation by macrophages from aged mice required longer periods of interaction 
between T cells and macrophages (59). This may be due to a feedback inhibition, which 
may rely on IFN-γ being produced by CD8 T cells. Macrophages have been shown to be 
activated in response to IFN-γ stimulation (60). Po et al. has demonstrated that IFN-γ 
production by CD8 T cells is delayed and decreased in aging (61). The extrinsic factors 
involved in T cell expansion and function is further demonstrated by the reduced capacity 
of T cells from young mice to work in an aged environment, suggesting that CD8 T cell 
dysfunction can be affected by extrinsic factors as well as intrinsic (19). These studies 
performed by Jiang et al. demonstrated that the adoptive transfer of specific CD8 T cells 
into young mice resulted in robust expansion of CD8 T cells while adoptive transfer of 
these same specific CD8 T cells into aged recipient resulted in reduced expansion of 
specific CD8 T cells (19). Collectively these studies suggest that during infection aged 
CD8 T cells suffer from both intrinsic and extrinsic defects, and these changes affect not 
only CD8 T cell function but the function of other cells as well. 
One extrinsic factor that may be involved in CD8 T cell function is Treg cells. 
These cells have been shown to effectively down-modulate the specific CD8 T cell 
response to several viral infections (62). In addition Treg cells percentage and number is 
increased in aged mice (63). However it has not been directly addressed whether or not 
Treg cells suppress the function of CD 8 T cells in aged mice during infection.  
Recent studies have demonstrated that aging affects many components of the 
immune response. While it has become increasingly obvious that innate immunity is 
affected by aging, many of these changes have been attributed to decreased T cell 
function. Changes in T cell function has been attributed to both intrinsic and extrinsic 
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changes in aging. It has been recently demonstrated that Treg cells can suppress T cell 
expansion function. Further it has been demonstrated that aged mice have an increased 
percentage and number of Treg cells (63, 64).  This increased proportion of Treg cells in 
aged mice may contribute to the extrinsic changes in the environment of aged mice that 
negatively affect T cell responses. To better understand the age-altered changes in 
immunity more attention should be paid to the environmental changes within aged mice, 
specifically changes which result in the suppression of T cell responses.  
 
1.2 Regulatory T cells 
1.2.1 Regulatory T cell History and Discovery 
 Like most other biological systems the immune system has several checks and 
balances in place to ensure homeostasis. These regulatory mechanisms are in place so 
that cells of the immune system are at a steady state during the resting phase, to ensure 
that the body doesn’t attack itself and that in response to invading pathogens the immune 
response reaches a protective level that is properly down-regulated to minimize or 
prevent tissue destruction.  
Immunological tolerance is usually divided into several categories: central, 
peripheral and induced. Central tolerance takes place in the thymus and begins with 
clonal deletion. Kappler et al. were the first to provide scientific proof that self-reactive T 
cells could be removed from the body as early as thymic development. They showed that 
a population of T cells whose TCR expresses the variant beta chain Vβ17α were 
pronounced in immature cells but following maturation these cells were absent. 
Vβ17α have been shown to strongly react with MHC class II. These results demonstrated 
  
12 
that during development this subset of T cells which strongly interacts with self-peptide 
naturally developed, but are selected for clonal deletion during T cell maturation to 
prevent immunological reactions to self (65).  Kisielow and colleagues also demonstrated 
that depletion of immature T cells occurs during the maturation process and that 
expression of not only the TCR but also of co-receptor CD4 or CD8 are needed for this 
depletion to take place at the CD4+CD8+ stage of development in the thymus (66).  Using 
αβTCR transgenic mice whose TCR responds to H-Y antigen (Y is a chromosomal 
histocompatibility chromosome antigen, found in male skin tissue; 67), Kisielow and 
colleagues demonstrated that compared to females, male Tg mice had a reduced number 
of total lymphocytes, as well as reduced numbers of H-Y specific CD8 T cells in the 
lymph nodes (66).   
Central tolerance protects from the initial development of self-reactive 
lymphocytes in the thymus. However, presentation of self-antigen to T cells by antigen 
presenting cells (APC) can occur within the periphery. Peripheral tolerance is responsible 
for preventing and reducing the effects of self-reactive immune cells in the periphery. 
Along with the idea of peripheral tolerance, induced tolerance can also protect the 
periphery from autoimmunity. Experiments using high dosages of antigen demonstrated 
that under such conditions the immune response can induce T cells to become 
unresponsive or anergic and suppress the response of other T cells to antigen. Gershon 
and Kondo introduced the idea of a sub-population of T cells that maintain peripheral 
self-tolerance. In the early 1970’s their study showed that thymus derived T cells were 
absolutely necessary for the induction of immune tolerance (68). Removal of the thymus 
prevented the immune system from protecting against autoimmunity. Reconstitution of 
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these thymectomized mice with T cells prior to immunization restored their ability to 
induce tolerance. While B cell tolerance was easily overcome by the addition of T cells, 
this was not the case for T cell tolerance (68). Penhale showed that when female rats 
were thymectomized and irradiated they had reduced numbers of total white blood cells, 
as well as T cells, in the spleen and lymph nodes and they ultimately suffered from 
autoimmunity. However when these mice were reconstituted with T cells they were 
rescued from autoimmune disease (69). Cantor and colleagues demonstrated that the 
subset of T cells responsible for the induction of tolerance was of the Ly-2+ sub-class of 
T cells (70). In addition these cells exhibited cytotoxic characteristics (71). While cells of 
the Ly1+ phenotype (commonly classified as helper T cells) were involved in the delay 
type hypersensitivity and antibody responses, Ly2+ T cells, were involved in cytotoxic 
responses. Further separation of these subclasses revealed that cells of the Ly-2+ 
phenotype were not only hyporesponsive to antigen but also in co-culture experiments 
interfered with Ly1+ cells responding to antigen. While such studies ignited the concept 
of a T cell that was capable of suppressing the immune response in order to protect from 
autoimmunity, the mechanism or the exact cell responsible for this function was not well 
defined. Although numerous studies promoted the idea of immunological tolerance by a 
T cell subset, known as suppressor T cells, there were no molecular studies to confirm 
these findings. Many immunologists, therefore, started to dismiss the idea.  
 Murphy et al. proposed a molecular marker for suppressor T cell function, which 
they originally mapped to the I-J subregion of the murine major histocompatibility 
complex (MHC). Murphy and colleagues described a new I subregion, I-J, located 
between the previously defined I-A and I-E subregions. In addition they reported that this 
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subregion coded genes which secrete suppressor molecules. These studies showed that 
suppressor, as well as helper, T cells exposed to anti-I-region sera were killed (72), 
demonstrating that without this region all T cells are rendered nonfunctional. While these 
experiments offered compelling data, Kronenberg and colleagues were able to show that 
no such region exists between the subregions I-A and I-E. Hybridomas were engineered 
which expressed suppressor proteins known to be produced by suppressor T cells; none 
of the proteins hybridized to the so-called I-J subregion (73).  
 While debate arose to whether or not a subpopulation of T cells exist that function 
in immunological tolerance, some scientists continued to examine and believe the idea 
into the mid-1980’s. Sakaguchi and colleagues used nude (nu/nu) mice which lack a 
thymus and therefore are completely void of T cells. In these studies anti-Lyt-1 or anti-
Lyt-2 sera were used to treat T cells prior to adoptive transfer into nu/nu host. Treatment 
of T cells with anti-Lyt-1 sera resulted in autoimmune disease, therefore the presence of 
Ly1+ cells is needed to protect from autoimmune disease. Co-transfer of Ly1+ cells alone 
or with Ly1-, 23- cells resulted in inhibition of autoimmunity. Such studies, which 
strongly demonstrate the presence of self-tolerance caused by a T cell, further confused 
the mechanism and phenotype of these cells, as other studies clearly demonstrated that 
these suppressor T cells were of the Ly2+ phenotype. This study and similar studies led to 
the questioning and ultimately dismissal of the concept of a population of T cells whose 
function is to induce tolerance. With failure to clone suppressor T cells or discovery of an 
exclusive marker to identify these cells, scientists in the field begin to doubt that these 
cells existed.  
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However, several studies continued to strongly suggest that immunological 
tolerance and suppressor T cells existed. Experiments continued to demonstrate that a 
subpopulation of T cells protected from several autoimmune diseases. In all of these 
studies the depletion of T cells or thyectomy resulted in deadly autoimmunity. Smith et 
al. demonstrated that T cells were involved in ovarian and gastric autoimmune disease 
(74); Sugihara et al. demonstrated that T cells were involved in thyroiditis following 
thymectomy (75); Morrissey et al. and Powrie et al. demonstrated that T cells were 
involved in wasting disease (76, 77); and Powrie et al. later demonstrated that a 
subpopulation of T cells was also involved in chronic intestinal inflammation (78). These 
studies also demonstrated that while a subpopulation of T cells protected from 
autoimmunity, a phenotypically and functionally different subpopulation of T cells were 
the cause of disease.  
 While numerous studies demonstrated that a subpopulation of T cells help 
maintain immunological tolerance, it was not until 1995 that strong evidence for this 
population was provided, ultimately re-kindling interest in suppressor T cells. Sakaguchi 
et al. offered a compelling argument that the suppressor T cells that protected from 
organ-specific autoimmunity constitutively expressed the complete IL-2R: α,β and γ sub-
chain (79). In this study Sakaguchi and colleagues demonstrated that the adoptive transfer 
of CD25+ (IL-2Rα subchain) depleted CD4+(helper) T cells into nude mice resulted in 
recipient mice spontaneously developing various autoimmune diseases, as well as graft-
versus-host wasting disease, while the adoptive transfer of CD4+CD25- T cells with 
CD4+CD25+ T cells prevented the development of disease. The findings of these studies 
helped establish a marker that was unique enough to identify suppressor T cells in naïve, 
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uninfected mice. (Note: Ly2+ cells were renamed CD8+ T cells and Ly1+ cells were 
renamed CD4+ T cells, after a workshop developed the CD (cluster differientation) 
system of receptors classification. This new description and identification of helper T 
cells and cytotoxic T cells, respectively, allows for a better distinction between T cell 
populations. Also these CD or receptors are found on the surface on all immune cells and 
are numbered in the order of their discovery.)  
Following this discovery it was suggest that suppressor T cells be re-coined 
regulatory T cells (Treg cells). Treg cells are responsible for protecting the host from 
autoimmunity, as well as insuring that in response to pathogens the immune response 
reaches a safe threshold which doesn’t result in excess tissue damage and destruction 
(46). Studies performed by Sakaguchi and colleagues also demonstrated that the thymus 
was needed to produce these T cells, since removal of the thymus by thyectomy 3 days 
after birth resulted in these cells being absent from the periphery and development of 
organ specific autoimmunity (80). While CD25 is constitutively expressed on Treg cells, 
CD25 is also expressed on virtually all T cells during an immune response. Expression of 
CD25 on T cells allows for T cells to bind growth cytokine IL-2 with high affinity, 
leading to increase effector activity and expansion of effector T cells. Therefore 
following immune activation additional markers are needed to differentiate between Treg 
cells and recently activated T cells.  
 Real time analysis of CD4+CD25+ Treg cells have shown that Treg cells express 
increased levels of foxp3 (~40-fold) compared to non-regulatory CD4+ T cells. Unlike 
CD25, foxp3 is not up-regulated following activation (81). Depletion of foxp3 results in 
autoimmunity similar to depletion of CD25+ T cells. Brunkow and colleagues determined 
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that a 2 base pair (bp) frameshift mutation that results in the production of non-functional 
foxp3 protein lead to the development of an autoimmune disease described as scurfy (82). 
These experiments, which resulted in the successful cloning of the wild-type foxp3 gene, 
provided evidence that foxp3 is essential for immune homeostasis. Importantly, foxp3 
was the first molecular marker identified to be unique to Treg cells in both naïve and 
stimulated T cells.   
Treg cells have been shown to develop naturally within the thymus as well as 
develop in the periphery in response to induced tolerance. The idea of immunological 
tolerance was discovered based on the theory that tolerance could be induced if the 
immune system was repeatedly activated using a high dose of antigen. This is referred to 
as induced tolerance. Studies to date provide evidence that not only does induced 
tolerance exist but also there are Treg cells which function in immunological tolerance.  
Today Treg cells have become as much of a reality as other lymphocyte subsets. 
It is not only well accepted that a subpopulation of T cells, Treg cells, exist to help 
discriminate between self and non-self, but also that these cells have the potential to be a 
therapeutic tool.   
 
1.2.2 Regulatory T cell Development 
The importance of Treg cells for an effective immune response and maintenance 
of immunological homeostasis remains uncontested. The complete absence of fully 
functional Treg cells due to genetic defects, molecular manipulation or selective 
depletion results in overwhelming autoimmunity and ultimately death shortly after birth 
(81). Acute peripheral ablation of the Treg cell populations also results in death of the 
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animal ~10 days post depletion (83, 84). The mechanism of Treg cell development, 
however, is a controversial subject.   
One fact that is agreed upon is that the thymus is absolutely required for the 
development of Treg cells. Sakaguchi and colleagues demonstrated that neonatal 
thymectomy 3-days after birth results in complete absence of CD4+CD25+ (Treg cells) 
and causes development of autoimmunity, with animals subcumbing to disease ~28 days 
after birth (85). Treg cells are identified in the thymus as early as 2 days after birth, with 
neonatal mice having an average of 1.5% of T cells in the thymus being CD4+CD25+ 
Treg cells and no evidence of Treg cells in the spleen (86). Using a foxp3gfp knock-in 
allele, Fontenot et al. demonstrated that foxp3 expression in CD4 T cells of the thymus 
doesn’t reach a plateau until approximately 21 days after birth (86). These studies also 
provided a mechanism for induction of autoimmunity in neonatal mice receiving 
thymectomies three days after birth: foxp3 doesn’t develop until 3 days post-natal, 
therefore the removal of the thymus prior to foxp3 results in no Treg cells in the mouse. 
Lio et al. described a thymically developed precursor for Treg cells.  These 
studies demonstrated that CD4 single positive (SP) thymocytes expressing high levels of 
CD25 and GITR (glucocorticoid-induced TNF-related protein), a marker also 
constitutively expressed by Treg cells, are highly enriched for foxp3+ Treg cells. 
Adoptive transfer of these CD4SP thymocytes results in increased percentages of Treg 
cells (87). These studies further showed that three days after intrathymic transfer of 
CD25hiCD4SP cells almost 14% Treg cells were detected compared to no development of 
Treg cells when mice were inoculated with CD25loCD4SP cells. While it has been 
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convincingly demonstrated that Treg cell development occurs in the thymus, the process 
by which these cells are selected is not well elucidated.  
Some models for Treg cell development propose that development occurs via an 
instructive pathway unique to Treg cells, which requires selection based on the TCRs 
affinity for self-antigen. Others propose a mechanism that does not require a negative or 
positive selection method for Treg cells, but hypothesiz that Treg cells development is a 
random event.  
Jordan et al. used a transgenic mouse model with TCR specific for self-antigen to 
demonstrate that T cells that recognize a self-peptide were usually CD25+ and functioned 
as Treg cells. They believe this ability to preferentially select self-reactive T cells to 
undergo Treg cell development demonstrates that Treg cells have a complete pathway of 
development separate from conventional T cells, concluding that the high affinity 
engagement of the TCR with self-antigen can lead to Treg cell development through an 
instructive method (88). Kawahata et al. demonstrated similar results by cross-breeding 
mice whose TCR reacts with OVA with mice expressing OVA in the nucleus of their 
cells. These Tg mice contained an increased number of Treg cells in both the thymus and 
periphery (89). Further Apostolou and colleagues reported that aberrant expression of 
agonist antigen by non-activated hematopoietic cells lead to the development of mostly 
Treg cells (90). 
Several studies compared the TCR specificity between CD4 T cells and Treg 
cells. Surprisingly these studies revealed that the TCRs of these populations overlapped 
greatly, with Treg cells expressing approximately 70% of CD4 T cell dominant TCRs. 
Another unexpected result was that only a small percentage of Treg cells had TCR 
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specificity for self-antigen, suggesting that high affinity interaction with self-antigen is 
not a requirement for Treg cells development (91, 92). These studies argue against the 
importance of TCR in Treg cell selection, demonstrating that the TCR of Treg cells does 
not have to respond to self-antigen. The similarities in TCR repertoire may suggest that 
the development of CD4 T cells and Treg cells may require the same signals, rather than 
a unique pathway of differentiation. Van Saten et al. proposes a model for selective 
survival of Treg cells, in which Treg cells are less responsive to agonist-induced clonal 
deletion. Using agonist peptides, their studies demonstrated that with increasing agonist 
CD4+ T cells begin to die due to clonal deletion, while Treg cells survive this phase and 
can escape clonal delecion. Van Saten argues that although the percentage of Treg cells 
increased, the actual number of Treg cells remained unchanged, suggesting that while 
development of CD4 T cells and Treg cells occurs at similar rates Treg cells may have an 
induced ability to survive clonal deletion (93).  
Hsieh et al. demonstrated that the TCR specificity of Treg cells found in the 
thymus differed from the TCR specificity of Treg cells in the periphery. The TCRs of 
Treg cells in the periphery resembled the CD4 T cell population in the periphery more 
than the TCRs of Treg cells in the thymus, suggesting that the TCR repertoire of Treg 
cells may be shaped more by peripheral interactions with self-antigen. The close 
overlapping of periphery-derived TCR Treg cells with periphery-CD4 T cells suggest that 
the TCR in fact does play a role in Treg cell selection and development (92).    
Ribot et al. demonstrated that the expression of super-antigen by thymic epithelial 
resulted in increased number and percentages of Treg cells, indicating that in addition to 
the TCR the thymic epithelial is involved in Treg cell development. This increase is not a 
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result of CD4SP clonal deletion, as irradation of Tg mice and reconstitution with 
thymocytes from MHC-deficient mice confirmed enhancement of Treg cell development 
(94). Further while Treg cells are sensitive to thymic selection it has been shown that they 
are unresponsive and are deleted in the thymus if they interact strongly with APCs 
presenting self-antigen (94, 95). These results demonstrate that Treg cells development 
occurs in a controlled and selective manner, similar to SP T cell development, however it 
has features unique to Treg cell development.  
While the TCR seems to be necessary for Treg cell development, the expression 
of CD4 may be less critical. Blache et al. demonstrated that in CD4-/- mice, CD3+CD8-
foxp3+ Treg cells are readily detected in the peripheral and these cells are able to suppress 
responder T cells (96). 
Constitutive expression of CD25 often lead researchers to believe IL-2 and its 
receptors play pivotal roles in Treg cells biology, including development, function and 
homeostasis. However, Burchill et al. demonstrated that IL-2 cytokine is not required for 
the development of Treg cells. In these studies IL-2-/- mice were able to produce Treg 
cells at percentages and numbers comparable to their littermate controls (97). In 
accordance with these results Fontenot et al. demonstrated that depletion of the IL-2Rα 
by genetic manipulation also had limited effects on Treg cell development (98). In 
contrast to studies using mice deficient in IL-2 or the IL-2Rα, depletion of the IL-2Rβ 
and γc (γ common chain) results in development of <0.5% of foxp3+ Treg cells (97, 99).  
A number of cytokines stimulate T cells through the γc:  IL-2, IL-4, IL-7, IL-9, IL-
21 and IL-15; however, only two of these γc cytokines rely on IL-2Rβ and γc chains, IL-2 
and IL-15 (99). Lio demonstrated that there is second phase of Treg cell development, 
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which is TCR independent and relies on both IL-2 and IL-15. In their studies they 
demonstrated that in vitro stimulation of CD4SPCD25hi T cells with IL-2 or IL-15 
induced foxp3 expression (87). Similarily, Burchill et al. demonstrated that activation of 
STAT5 is required for the development of Treg cells since activation of the STAT5 
pathway has been shown to induce the expression of foxp3. Interestingly both IL-2 and 
IL-15 can bind the γc of the IL-2R, as well as induce the activation of STAT5 (97). 
Collectively, experiments using IL-2-/- or IL-2R-/- mice demonstrate that Treg cells 
development requires IL-2 and its receptor; however in the absence of IL-2 or its high 
affinity binding subunit IL-2Rα, IL-15 can partially compensate for IL-2 in development.  
Expression of foxp3 has been shown to be the final stage of Treg cell 
development. Lio et al. proposed that the induction of foxp3 occurs following TCR 
signaling (87).  Foxp3-/- mice do not develop Treg cells. Flow cytometric comparison of 
CD4+CD25+ T cells from foxp3+/+ and foxp3-/- mice demonstrated that 10 days after birth 
foxp3-/- mice did not develop CD4+CD25+ T cells, however 28 days after birth an 
activated population of CD4 T cells begins to develop. Uncharacteristic of Treg cells, 
these cells expressed varied amounts of CD25, proliferated in response to TCR 
stimulation and failed to suppress the proliferation of CD4 effectors T cells (81). Foxp3-/- 
mice usually succumb to death within 28 days, similar to mice deficient in CTLA-4 or 
IL-2R. In addition induced expression of foxp3, via genetic manipulation, has been 
shown to convert CD4+foxp3- hyper-responsive cells into CD4+foxp3+ cells that are 
hypo-responsive to stimulation and can suppress the expansion of CD4+ responder T cells 
(100).  
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While Treg cells are believed to occurr naturally through thymic development, it 
has also been shown that naïve and resting CD4 T cells can be induced to Treg cells in 
the periphery. These Treg cells are referred to as induced Treg cells (iTreg cells) (101). 
Groux and colleagues demonstrated that CD4+CD25- T cells could be induced to become 
Treg cells. Using Tg OVA-mice, they demonstrated that with repeated stimulation with 
OVA and APCs in the presence of IL-10, CD4+CD25- T cells could be induced to have 
suppressor function (102).  These initial studies led to the identification of regulatory T 
cells type 1 (Tr1) as a periphery induced Treg cell population. These results were further 
confirmed by Levings et al. who demonstrated that immature DCs can induce CD4 T 
cells in the presence of IL-10 to become Tr1 cells (103). Tr1 cells described in both 
publications had cytokine profiles different from the classical helper T cell profiles (Th1, 
Th2 and Th0). Tr1 cells produce high levels of anti-inflammatory cytokines IL-10 and 
TGF-β, with very low levels of IL-2 and IL-14, opposite to the cytokine profile of 
effector T cells (102, 103).  
Oral tolerance has been shown to induce the development of a second subset of 
iTreg cells referred to as Th3 regulatory cells (104). In these studies Weiner and 
colleagues demonstrated that feeding mice low dosages of myelin basic protein (MBP) 
results in the production of regulatory cells that can suppress effector T cells in vitro and 
in vivo. These orally induced Tregs protected animals from developing autoimmune 
encephalomyelitis (EAE) by secreting high levels of TGF-β. In addition these studies 
demonstrated that both CD4 and CD8 T cells could be orally induced to become Th3 
cells (104).   
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Treg cell development appears to be a controlled process which we are only 
beginning to understand. In addition to thymic development, Treg cells also develop in 
the periphery. As we begin to better understand which conditions drive the development 
of Treg cells, we can better manipulate these cells. For example it has been demonstrated 
that decreased development of Treg cells increases susceptible to immunological 
disorders such as autoimmunity (105), whereas increased production of Treg cells, which 
is believed to be the case in prolonged infection or aging, reduces the immune response to 
antigen (63, 106). Understanding the development of Treg cells will allow for better 
treatment in cases where immune regulation specifically Treg cell development is 
imbalanced.   
 
1.2.3 Natural Treg function 
 While the mechanism of Treg cell inhibition is not fully understood, some studies 
have started to unravel the complex function of these cells (107). The expression of the 
complete IL-2R (IL-2α chain along with the β and γ chains) on the surface (108) is a 
hallmark of Treg cells. Sakaguchi et al. were the first to demonstrate a role for IL-2 and 
IL-2Rα in Treg cells function (79).  Sakaguchi et al. reported that the transfer of CD4 T 
cells alone could not protect immunocompromised mice from autoimmunity, however 
the adoptive transfer of a subpopulation of CD4 T cells that constitutively express CD25 
could induce protection from autoimmunity (79). While IL-2 and IL2Rα are not required 
for the development of Treg cells, mice deficient in either IL-2 or CD25 have a reduction 
in the percentage of peripheral Treg cells. These studies demonstrated that both IL-2 and 
its high affinity receptor is required for the activation and homeostasis of a fully 
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functional Treg cell population in the periphery (109). Specifically D’Cruz et al. 
demonstrated that IL-2-/- mice experienced a significant decrease in peripherial Treg cells, 
both CD25+ and CD25+foxp3+. In addition their studies demonstrated that adoptive 
transfer of CD25+ Treg cells into IL-2-/- mice resulted in poor survival of the adoptively 
transferred cells (110). Lastly adoptive transfer of T cells from CD25-/-mice failed to 
protect immunocompromised hosts from autoimmunity, while CD25+/+ cells induced 
protection (111).   
Although CD25 is vital in both the identification and function of Treg cells, the 
importance of foxp3 expression in Treg cells cannot be ignored. As stated previously, 
absence of foxp3 protein results in the absence of Treg cells that are able to suppress 
hyper-proliferative CD4 T cells and renders the host susceptible to autoimmune disease. 
In addition foxp3 expression is not induced by stimulation of T cells, therefore foxp3 is 
also essential in the identification of Treg cells during an immune response. Wan et al. 
proposed that foxp3 controls the function of Treg cells in a dose dependent manner. In 
these studies a mouse model expressing foxp3 at decreased levels were compared to 
control mice expressing foxp3 at normal levels. Treg cells isolated from mice with 
reduced foxp3 expression were inefficient at suppressing responder T cells, and adoptive 
transfer of these foxp3lo expressing T cells failed to protect immune compromised mice 
from autoimmunity (112).  
In addition to the constitutive expression of CD25 and foxp3, other markers 
constitutively expressed on Treg cells have also been shown to been involved in the 
function of Treg cells. It has been shown that a greater percentage of foxp3+ T cells 
express Glucocorticoid Induced TNF receptor (GITR) than CD25. In these studies 
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performed by Ono et al. while ~75% of foxp3+ cells expressed CD25, more than 90% 
expressed GITR. Treg cells also constitutively express cytotoxic T-Lymphocyte Antigen-
4 (CTLA-4). Takahashi et al. demonstrated that the addition of anti-CTLA-4 fab 
fragment interfered with in vitro suppression of T cells in a dose dependent manner 
(113). Paust and colleagues determined that the expression of CTLA-4 ligand B7 on T 
cells is necessary for the suppression of T cells by Treg cells. In their studies the adoptive 
transfer of B7-/- CD4 T cells with CD4+CD25+ Treg cells were not able to protect rag2-/- 
mice from autoimmunity, while the co-transfer of wt B7 CD4 T cells with CD4+CD25+ 
prevented autoimmunity. CTLA-4 ligand B7 is sometimes referred to as B7-1 (CD80) 
and B7-2 (CD86). Paust et al. further demonstrated the role of CTLA-4 in the function of 
Treg cells; they reported that removal of B7 ligand abrogates the suppression of CD4 T 
cells by Treg cells. In these studies retroviral transfection of cDNA expressing CD80 and 
CD86 restores the ability of Treg cells to suppress co-transferred B7-/- CD4 T cells and 
protect from autoimmunity (114).   
The surface receptors constitutively expressed on Treg cells have been shown to 
play a prominent role in its function. In addition studies have begun to demonstrate that 
cytokines are also involved in Treg cells function. Specifically anti-inflammatory 
cytokines IL-10 and TGF-β have been shown to be involved in regulation of the immune 
response. Many studies assessing the importance of IL-10 in Treg cells function rely on 
the surface marker CD45RB, which is expressed on the surface on T cells. This marker is 
up-regulated following thymic selection (CD45RBhi) and is decreased following 
peripheral activation (CD45RBlo). It has been shown that CD45RBlo cells contain a 
proportion of CD4+CD25+ Treg cells, which can protect from autoimmunity when 
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adoptively transferred with CD45RBhi cells into T cell depleted mice (115).  The 
adoptive transfer of CD45RBloCD25+ T cells from IL-10-/- mice along with CD45RBhi T 
cells cannot control the proliferation of T cells in response to alloantigen. In addition 
treatment of recipient mice with anti-IL-10 modulates this suppression and results in 
autoimmunity in recipient mice (115, 116).  
IL-10 has also been shown to be a play a major role in the function, of peripheral 
induced Tr1 cells. IL-10 has been shown to have a negative impact on the immune 
response and IL-10-/- mice demonstrate increased inflammatory responses to infection 
(117). Levings et al. has demonstrated that iDCs can promote the differentiation of CD4 
T cells into Tr1 cells and that differentiation of CD4 T cells into Tr1 cells requires the 
production of IL-10 by iDCs (103).  This demonstrates a cooperative role for IL-10 and 
DCs in the immunoregulatory function of Treg cells. Upon induction Tr1 cells secrete IL-
10, which suppresses the inflammatory response in mice during infection (118).  
  Cytokine TGF-β  is also involved in the suppressive function of Treg cells. TGF-
β  dependent suppression of T cells appear to be important in autoimmune diseases 
caused by CD8 T cell responses such as tissue transplantation as well as during tumor 
rejection (119). It has been convincingly demonstrated by Chen et al. and Grenn et al. 
that Treg cells are not able to suppress CD8 T cells expressing a dominate negative form 
of the TGF-β receptor in vivo. In these studies wt CD8 T expansion and function was 
suppressed by specific Treg cells, however depletion of the TGF-β receptor CD8 T cells 
rendered CD8 T cells unresponsive to suppression by Treg cells (62, 120). TGF-β1 null 
mice suffer from autoimmunity disease following normal cell growth for the first two 
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weeks. These mice develop a wasting disease and subcumb to death 3-4 weeks after birth 
(121).  
While the above in vivo studies have provided information regarding the 
mechanism of Treg cells suppression, the study of Treg cells function in vivo has limits. 
For example it is hard to distinguish the source of anti-inflammatory cytokines in infected 
mice. In addition it is difficult to define the role of other immune cells in Treg cell 
function. In vitro studies of Treg cells allows for further manipulation of Treg cells 
independent of the other immune cells and cytokines involved in immune regulation.  
Following the rediscovery of Tregs in the mid-1990’s (79), Shevach and 
colleagues developed an assay to study the function of this complex sub-group of CD4+ T 
cells in vitro. The assay developed by Thorton and Shevach (122) relies on the 
enrichment of Treg cells using the CD4 and CD25 molecules on their cell surface. 
Following the two-step process of CD4+CD25+ enrichment, Treg cells can be co-cultured 
with a responder cell, CD4 or CD8 T cells, to determine if the presence of these Treg 
cells can affect the function or expansion of the responder cells upon stimulation with 
anti-CD3, mitogen or specific antigen. This assay has allowed the comparison of 
suppression of Treg cells isolated from different strains and ages of mice, as well as 
examination of some of the external condition which must exist for successful 
suppression to occur. 
Treg cells suppress the proliferation of CD4 T cells in vitro through contact 
dependent mechanisms, as separation of Treg cells from responder CD4 T cells using a 
transmembrane well resulted in complete abrogation of suppression. Thorton et al. further 
demonstrated that although CD4+CD25+ Treg cells appear to be in an activated and 
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hypoproliferative state, they do not proliferate in response to TCR stimulation. However 
the hypoproliferative state of Treg cells during in vitro stimulation can be overcome by 
the addition of IL-2 to cells cultures and this addition of IL-2 completely abrogates 
suppression leading to proliferation of Treg cells and enhancement of CD4 T cell 
response in a dose dependent manor. While the addition of excessively large amounts of 
IL-2 interfere with Treg cell function, it has been shown that Treg cell survival and 
function require IL-2; addition of IL-2 in small amounts leads to better recovery of Treg 
cells approximately four days after culture compared to Treg cells cultured without IL-2. 
Treg cells cultured in the presence of exogenous IL-2 are also more potent suppressors of 
CD4 T cells (58, 112, 122, 123). Taken together these studies demonstrate a vital role for 
IL-2 in the homeostasis and function of Treg cells in vitro, in a dose dependent manner.  
De la Rosa et al. also demonstrated a role for IL-2 in in vitro suppression assays 
(108). Blockage of the IL-2Rα and β on Treg cells chain by antibody abrogates the 
suppression of human CD4 responder T cells. They argue that the constitutive expression 
of the complete IL-2R allows Treg cells to compete with CD4 T cells for IL-2. They also 
noted that the addition of exogenous of IL-2 leads to increased production of IL-2 mRNA 
by responder CD4 T cells. The competitive consumption of IL-2 by Treg cells and CD4 T 
cells is believed in part to be due to repressed IL-2 production in Treg cells. Specifically 
Rao and colleagues have shown that the cooperative binding of foxp3 with Nuclear factor 
of activated T-cells (NFAT) inhibits the production of IL-2 by Treg cells (124).  
The establishment of an in vitro assay to study the function of Treg cells has been 
a major contribution to Treg cell biology, however several studies argue that suppression 
seen in in vitro assays may not fully demonstrate the mechanism of Treg cells in vivo. In 
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particular there continues to be heavy debate as to whether or not inhibitory cytokine IL-
10 and TGF-β play a major role in cytokine suppression versus Treg cell suppression 
being completely contact dependent. Most studies note that the difference between 
contact dependent and cytokine dependent suppression depends on the experimental set 
up in vivo versus in vitro. Studies performed by Barthlott and colleagues provided 
evidence that competition of IL-2 with responder cells lead to the production of IL-10 by 
CD4+CD25+ cells in vitro (108, 125).  The initial in vitro Treg cells studies performed by 
Thorton et al. demonstrated a role for IL-10 in the in vitro suppression of T cells as well. 
In these studies Treg cells isolated from IL-10-/- mice or mice deficient in IL-10 inducing 
cytokine IL-4 did not suppress CD4 responder T cells (122). While these early in vitro 
studies evaluating the mechanism of CD4+CD25+ Treg cells demonstrate a role for 
cytokines in suppression, other studies contradict these results as addition of neutralizing 
antibodies to IL-4, IL-10 or TGF-β had no effect on Treg cell suppression in vitro (46). 
While TGF-β fab fragment did not interfere with T cell suppression, it was reported by 
Nakamura et al. that stimulation of Treg cells with CTLA-4 enhances the proliferation of 
Treg cells and induces the production of TGF-β1 by Treg cells. These results demonstrate 
that Treg cell function is not affected by TGF-β stimulation, and Treg cells in fact do 
produce high titers of TGF-β1 when stimulated under certain conditions (126).  
There has been important findings in Treg cell function which further validates 
their presence, however in order to use Treg cells as a potential target for therapy in 
infection and disease the mechanism of action needs to be further elucidated. 
Specifically, the importance of Treg cells being within close proximity of its target cell 
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for Treg cell suppression to occur and the dependency of suppression on specific 
cytokines needs to be established.  
 
1.3 Regulatory T cells and Aging 
While TCR specificity may be important in Treg cells development, suppression 
is non-specific. Treg cells can exert their suppression on multiple targets, including T 
cells, B cells, NK cells and APCs (127-129). This nonspecific suppression of numerous 
targets could be an area of concern when unusually long and robust immunity is required 
in cases such as infection and tumor immunity. In addition recent findings suggest that 
the increased percentage of Treg cells found in aged mice and humans may be related to 
immunodeficiencies commonly seen with aging (63, 130). Aged mice demonstrate 
increased percentages of CD4+CD25+ in the thymus and periphery compared to young 
mice (63, 131).  Some studies also report an increase in periphery CD4+CD25+ Treg cells 
in humans (64), while others suggest no difference (132). 
Initial reports describing Treg cells defined these cells based on constitutive 
expression of CD25 on the surface of CD4 T cells and this identification worked well in 
both young mice and humans (79). However studies performed by Nishioka et al, 
demonstrated that identification of Treg cells by CD25 wasn’t sufficient in aged mice 
(63). These experiments demonstrated the importance of foxp3 in Treg cell identification 
in aged mice as some CD4+CD25+ T cells may actually be activated CD4 T cells that do 
not express foxp3 (63).  Lages et al. expanded on these results demonstrating that aged 
humans had increased percentages of circulating CD4+foxp3+ Treg cells and that both 
spleen and lymph nodes of aged mice had increased percentages of CD4+foxp3+ Treg 
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cells, however there were no differences in Treg cells when comparing the peripheral 
blood of young and aged mice (133). 
While studies consistently report increases not only in the percentage but also in 
the number of Treg cells in aged mice, the difference is not always significant. Sharma et 
al. and Zhao et al. have reported a significant increase in the number of Treg cells in 
Balb/c mice (134, 135). Increased number of Treg cells in aged C57BL/6 mice has also 
been reported; however studies performed by Nishoika et al. demonstrates a slight 
increase in Treg cell number which is not significant while Chui et al. reports a 
significant difference (63, 136). The difference in these results may be due to the 
definition of Treg cells phenotype in these experiments. While Nishoika et al. calculated 
the absolute number of CD4+CD25+ T cells, studies performed by Chui used foxp3 as the 
marker of Treg cells. These reports may be further impacted by the number of T cells 
isolated from young and aged mice as some studies demonstrate an increase in T cell 
number in aged mice, while other studies demonstrate a reduction in T cells in aged mice 
(19).  
Assays comparing the suppressive ability of Treg cells from aged and young mice 
report conflicting results. Several studies have demonstrated that Treg cells isolated from 
both young and aged mice suppress the proliferation of effector CD4 T cells at similar 
levels. In these studies the addition of Treg cells to effector T cell cultures reduces T cell 
proliferation in response to TCR stimulation and no difference was seen when adding 
Treg cells isolated from young or aged mice (63). Zhao et al. demostrated that Treg cells 
isolated from young and aged mice suppress the proliferation of T cells at similar levels. 
However their studies show that Treg cells from aged mice were unable to suppress the 
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secretion of growth cytokine IL-2 by effector T cells as effectively as Treg cells isolated 
from young mice. In addition an in vivo study revealed that aged mice had a reduced 
ability to inhibit delayed type hypersensitivity (DTH) responses compared to young 
(135). Similar to several studies in mice Treg cells isolated from aged individuals were 
able to suppress CD4 T cell proliferation at levels comparable to Treg cells isolated from 
young individuals (64). In contrast Lages et al. reported that aged Treg cells were more 
suppressive compared to young Treg cells in both humans and mice. Specifically Treg 
cells isolated from aged GFP-foxp3-knock-in mice were more suppressive in inhibiting 
CD4 T cell responses compared to Treg cells isolated from young GFP-foxp3-knock-in 
mice, although the isolation of Treg cells from a knock-in mouse could be the 
confounding factor resulting in differences in Treg cells function in these studies (133).  
The ability of freshly isolated Treg cells to suppress effector T cells as well as the 
mean fluorescent intensity (MFI) of markers constitutively expressed on Treg cells are 
common methods for evaluating the phenotype and function of Treg cells. In comparison 
to conventional CD4 T cells, both thymic and peripheral Treg cells constitutively express 
a higher percentage of CD69, CTLA-4, GITR, CD25 and foxp3 (79, 81, 137-139). These 
markers constitutively expressed on the surface of Treg cells have been shown to inhibit 
the activation and expansion of effector T cells, early expression of ligands by Treg cells, 
interfere with immune activation, specifically these ligands bind to activation receptors 
on APCs and interfere with activation of effector T cells (81, 98, 114, 137, 140). In 
addition surface markers related to a memory phenotype are expressed on Tregs so 
several studies take into account the differences in expression of CD44, CD45RB and 
CD62L (135, 141). As stated earlier there are no differences in the level of expression (as 
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determined by MFI) of foxp3 on CD4+CD25hi or CD4+foxp3+ Treg cells isolated from 
young or aged mice. There also appears to be no known differences between GITR 
expression in young versus aged Treg cells (63, 133). MFI of CD25 is reduced on Treg 
cells from aged compared to young mice. Significant differences have also been reported 
in the MFI of CD69, CTLA-4 and CD62L. CD69 and CTLA-4 expression is increased on 
aged Treg cells while CD62L is decreased (133, 135). Zhao et al. argue that this finding 
of reduced function of Treg cells in aged mice is further demonstrated by the decreased 
expression of CD62L as studies have shown that CD4+CD25+CD62Lhi Treg cells are 
more potent suppressors than CD4+CD25+CD62L- cells (135). It could also be reasoned 
that the increased expression of CD69 and CTLA-4 could be in relation to an increased in 
Treg cells function. These findings suggest that the function of Treg cells of young and 
aged mice need to be further evaluated to determine if there are functional differences 
between the cells.  
Further studies illustrate that not only are Treg cell increased in both aged mice 
and humans, but that these Treg cells may interfere with tumor immunity and exacerbate 
infectious disease in aged mice (133, 134). Although incidents of cancer rise in the 
elderly and the anti-tumor response is reduced with aging, there is no clear indication as 
to why this occurs. Several studies have begun to link the increase incidence of cancers in 
aging to Treg cells (142). It has been shown that aged mice can develop a strong 
antitumor response if age-altered hypo-responsive CD8 T cells are properly co-stimulated 
(143). This study and others argue that the reduced antitumor responses of aged mice are 
a result of the environment and not intrinsic defects within the T cells. Sharma et al. 
demonstrated that increased proportions of Treg cells interfere with tumor immunity and 
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inactivation of these cells with mAb to CD25 (PC61) could restore tumor immunity. In 
these studies, pre-treatment of aged mice with PC61 prior to the adoptive transfer of pre-
B lymphoma tumor cells led to anti-tumor responses similar to young mice receiving 
tumor cells, while aged mice without PC61 treatment ultimately developed tumors and 
succumbed to death ~20 days after inoculation. Specifically the depletion of Treg cells 
led to the restoration of CD8 T cell responses (134). Similarly, it was initially 
demonstrated that vaccination of aged mice with TLR ligand cytosine-phosphate-
guanosine (CpG) -containing oligodeoxynucleotides (ODN) could enhance the anti-tumor 
response of aged mice. It was later reported by Sharma et al. that CpG-ODN reduces the 
accumulation of Treg cells in aged mice (134).  Taken together these results 
demonstrated that increased percentages of Treg cells could have a negative impact on 
the anti-tumor responses. Additionally it appears that increased co-stimulation of T cells 
can over come the suppression of Treg cells.  
The accumulation of Treg cells at the primary site of infection has been shown to 
interfere with clearance of Leshmania parasites. Lages et al. demonstrated that following 
acute infection of Leshmania in 2-month-old mice disease becomes latent. As the mice 
age they spontaneously reactivate disease with reactivation of disease occurring in ~75% 
of mice by 105 weeks post-healing (133). Adoptive transfer of Treg cells from 
Leishmania infected mice can trigger reactivation of infection in mice with latent disease, 
while mAb depletion of Treg cells increases the response to parasites and prevents 
reactivation of disease (144, 145).  
Collectively the experiments performed evaluating the number, percentage and 
function of Treg cells in relation to the immune response demonstrate that Treg cells can 
  
36 
effectively suppress effector cell function and down-modulate the immune response. 
Therefore the increase in Treg cell percentage in aged mice could interfere with various 
immune responses to foreign pathogen. In addition many studies have demonstrated that 
an imbalance of effector T cells and Treg cells can have serious disease consequences not 
just limited to animal studies. Belkaid et al. argue that changes Treg cells percentage and 
number can lead to prolonged survival of foreign pathogens and onset of disease in 
humans and mice (146). Inactivation or removal of Treg cells during viral infection and 
tumor immunity is a promising area of therapeutic treatment in aged patients. By 
removing a percentage of Treg cells there may be more available space for effector T cell 
expansion, and may also lead to enhanced effector T cell function. Experiments should be 
performed to determine if reducing the percentage of Treg cells in aged mice increases 
the age-altered immune response.  
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Chapter Two: Hypothesis and Specific Aims 
 
Many studies have demonstrated that aging is associated with a decreased immune 
response. Age-associated changes have been identified in both humoral and cell-mediated 
immunity, with the most dramatic and consistent changes being seen within the T cell 
compartment, including a decrease in T cell activation, expansion and altered cytokine 
patterns (147). Our lab has consistently shown that aged mice exhibit a delay and 
decrease in specific CD8+ T cell expansion and cytotoxicity following both lymphocytic 
choriomeningitis virus (LCMV) and influenza infections (19, 61). These changes are the 
results of both intrinsic and extrinsic factors. Recent data indicate that naïve aged mice 
have an increased number and percentage of regulatory T cells (Treg cells) as compared 
to their younger counterparts (63, 135). This subpopulation of CD4+ T cells constituently 
expresses the IL-2Ra chain (CD25) and transcription factor foxp3 and has been shown to 
down regulate the immune response (79, 148).  
Hypothesis: Increased proportions of Treg cells in aged mice interfere with specific 
CD8 T cell expansion and function.  
Based on the limited and sometimes conflicting data in the literature three specific 
aims were developed to further characterize Treg cells and their role in the altered 
immune response in the aged. They are: 
I. Examine regulatory T cell kinetics in vitro in response to non-specific 
stimulation with concanavalin A (ConA) in young and aged mice. 
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II. Compare the suppressive function of young and aged mice in vitro in 
response to antigen stimulation 
III. Determine if Treg cells in aged mice respond differently to in vivo 
influenza infection compared to young mice 
 
The goals outlined in this thesis will help determined if the increased percentage and 
number of Treg cells found in aged mice can be linked to the age-associated changes in 
CD8+ T cell expansion and function.  We have proposed several possible outcomes for 
this project (Figure 2.1). 
 
 
 
Figure 2.1 Possible outcomes when comparing Treg cell percentage and function in 
young and aged mice.  
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Chapter Three: 
Regulatory T Cell Depletion in Young and Aged Mice Following in vitro Stimulation 
with Concanavalin A 
 
Yolanda Williams-Bey, Jiu Jiang, Joseph Fuller and Donna M Murasko* 
Department of Biology, Drexel University 3141 Chestnut St, Philadelphia, PA 
Abstract 
It has been well demonstrated and generally accepted that aging results in a 
weakened immune response in both humans and rodents. Recently it has been established 
that aging is associated with a expansion of the regulatory component of the immune 
system, specifically an increase in the percentage of regulatory T cells (Treg cells). 
Numerous studies have demonstrated a reduced capacity of T cells from aged humans 
and mice to respond to mitogenic stimulation in vitro; however the mechanisms of the 
diminished response have not been completed delineated. In this study we evaluated the 
role of Treg cells in the reduced T cell response of aged mice following in vitro ConA 
stimulation. While the results from these experiments confirm that T cell activation and 
expansion are reduced in aged mice and that splenocytes from aged mice contain an 
increased proportion of Treg cells, the percentage of Treg cells is quickly reduced in both 
young and aged mice after in vitro stimulation. Further, depletion of Treg cells has little 
impact on T cell response of aging. Therefore, it appears that Treg cells are not major 
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component of the decrease response of T cells of aged mice to in vitro mitogenic 
stimulation.  
 
3.1 Introduction 
Many studies have demonstrated that aging is associated with a decrease in the 
immune response. Changes have been observed in both the humoral and cell-mediated 
response (147). The most dramatic and consistent changes have been seen within the T 
cell compartment, including a decrease in T cell activation, expansion and alterations in 
the production of cytokines being produced by T cells (40).  These changes have been 
attributed to both intrinsic changes within the T cell, as well as extrinsic changes within 
the environment of these cells function (40).  
The mitogenic stimulus Concanavalin A (ConA) is a plant lectin isolated from the 
jack bean Canavalia ensiformis  that has been shown to efficiently activate T cell 
responses. Specifically it has been shown that ConA stimulation leads to the up-
regulation of high-affinity receptor IL-2Rα (CD25) and production of growth cytokine 
IL-2, causing the activation and expansion of T cells (149, 150). We have previously 
demonstrated that splenocytes isolated from aged mice respond poorly to ConA 
stimulation (47). However little attention has been paid to the effect of ConA stimulation 
on Treg cells.  
Along with changes occurring in the humoral and cell-mediated responses of aged 
mice, several studies have reported a change in the percentage of Treg cells in aging (63, 
135). Sakaguchi et al. were the first to demonstrate that a CD4 T cell sub-population 
constitutively expressing IL-2Rα (CD25) could protect immunocompromised mice from 
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autoimmunity (79). Treg cells are responsible for maintenance of self-tolerance: they 
protect the body from unwanted immune responses as well as down-regulate the immune 
response following activation to minimize tissue damage and destruction (46). While 
these cells have an important role in protecting the body from an autoimmune response, 
increasing numbers of Treg cells can have a negative effect on the response needed for 
prolonged immune activation such as chronic infection and tumor immunity (151, 152).  
The increasing percentage of Treg cells in aged mice needs be evaluated for their role in 
the reduced T cell response to non-specific stimulation.  
We hypothesized that the increased percentages of Treg cells in aged mice could 
contribute to the reduced expansion of T cells isolated from aged mice. We evaluated the 
response of T cells of individual mice to conA stimulation. We confirmed previous 
reports that demonstrate both CD4 and CD8 T cells from aged mice have a decrease in 
activation and expansion and that aged mice demonstrate an increase in the percentage of 
Treg cells (CD4+CD25+foxp3+ and CD4+CD25+). Interestingly, depletion of Treg cells 
enhanced activation and expansion of T cells in response to ConA stimulation in young 
but not aged mice. ConA stimulation also results in a decreased percentage of Treg cells 
in young and aged mice.  
 
3.2 Materials and Methods 
Mice 
Young (4-7 months) and aged (>20 months) C57Bl/6 mice were purchased from the NIA 
at Harlan Sprague Dawley (Indianapolis, IN). All mice were maintained in AAALAC-
approved barrier facilities at Drexel University (Philadelphia, PA). Mice were allowed to 
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acclimate for at least one week in our animal facilities prior to use. Mice exhibiting 
enlarged spleens or tumors were eliminated from this study. All experiments involving 
mice were conducted with the approval of the Institutional Animal Care and Use 
Committee (IACUC) of Drexel University.  
ConA Stimulation 
Splenocytes were isolated from young and aged mice and resuspended in complete media 
containing 5% FBS with 2-ME (β-mercapthenol), gentamycin and L-glutamine. Cells 
were added to a 96-well plate at concentrations of 2x105 cells per well then stimulated 
with 2.5 ug of ConA. Cell cultures were incubated for allotted time at 37oC with 5% CO2.  
Proliferation Assay 
A) Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE) Staining. Isolated 
splenocytes were incubated with PBS and CFSE for 10 mins at room temperature then 
washed in buffer containing 10% PBS. Fold change in CFSE MFI was calculated relative 
to negative controls (MFI of unstimulated CD8 T cells / MFI of stimulated CD8 T cells). 
B) Tritium thymidine [3H] Incorporation. Proliferation was evaluated by addition of 
radioactive 3H thymidine to cell cultures during the last 4 hours of culture. Samples were 
evaluated for radioactivity per well, and reported as radioactivity counts per minute.  Net 
cpm= cpm with mitogen – cpm without mitogen.  
Analysis of Cell Populations 
At each 24-hour interval, cell cultures were stained with surface antibodies that recognize 
CD4, CD8, CD25 and CD69 at 4oC for 30 mins, followed by cell fixation and 
intracellular staining for foxp3 at 4oC for 30 mins.   CD8 T activation was analyzed by 
gating on CD8 T cells as the parent population then evaluating the percentage of CD8 T 
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cells that express CD25 or CD69. Expansion was analyzed by gating on CD8 T cells as 
the parent population then evaluating the MFI of CFSE. Treg cells were also analyzed by 
gating on CD4 T cells as the parent population and evaluating the percentage of cells 
which express CD25 or CD25 and foxp3.  
Annexin V Staining  
Annexin V staining was performed according to the manufactures protcol. Briefly, 1x106 
splenocytes were staining at room temperature for 15 minutes with 5 ul of PE-labeled 
annexin V. Staining was evaluated by FACS analysis.  
CD4+CD25+ T Cell Depletion 
Depletion of CD25+ CD4 T cells was performed using MACS separation columns 
according to the manufactures protocol. Briefly, isolated splenocytes are resuspended in 
PBS buffer containing BSA, then labeled with antibody specific for CD25 and passed 
through an octoMACS for the removal of CD25+ T cells. As most T positive for CD25 is 
of the CD4 phenotype, there was no need to perform a CD4 deletion step. 
 
3.3 Results 
Reduced activation and expansion of Treg cells in aged mice following ConA stimulation 
in vitro  
 The function of freshly isolated cells was assayed by their ability to activate and 
expand in response to ConA stimulation in vitro. Aged mice have a reduced capacity to 
expand as shown by reduced 3H-thymidine incorporation following 48 hours of 
stimulation, with young mice demonstrating 3H-thymidine incorporation at rates two-fold 
higher than splenocytes from aged mice (Figure 3.1A). We also compared the expansion 
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of T cells from young and aged mice using the cytoplasmic stain CFSE, which is 
distributed equally between daughter cells upon proliferation (153). While CD8 T cell 
expansion is apparent in T cells from young mice 48 hours post stimulation, no expansion 
of CD8 T cells from aged mice is observed until 72 hours and this expansion is reduced 
compared to CD8 T cells from young mice. Importantly, at 96 hours post stimulation 
aged mice have a significant percentage of T cells that fail to proliferate in response to 
ConA stimulation (Figure 3.1B).  
There were also significant reductions in the percentage of CD4 and CD8 T cells 
which up-regulate the expression of IL-2Rα (CD25) or early activation marker CD69 
(Figure 3.2). CD25 expression is required for T cells to bind the proliferative cytokine IL-
2 and binding of IL-2 by effector cells not only leads to expansion but also increased 
helper or cytotoxic function by CD4 and CD8 T cells, respectively (154). Whereas the 
exact role of CD69 is unknown, it is an early marker expressed by recently activated 
effector T cells (155).  Following ConA stimulation CD 4 T cells isolated from young 
mice not only have a higher percentage of CD25+ CD4 T cells, but they also continue to 
express this marker at higher percentages through the four days of stimulation compared 
to aged T cells, whose expression of CD25+ is reduced and begins to decline before T 
cells of young mice (Figure 3.2A). Percentages of CD4 T cells expressing CD69 is 
increased on T cells from young mice and begins to decline following 24 hours of 
stimulation. While the expression of this molecule is reduced on T cells from aged mice, 
the disappearance of CD69 is slower on T cells from aged mice (Figure 3.2B). 
Interestingly, following 96 hours of stimulation, T cells from aged mice continue to have 
a significant percentage of T cells, particularly CD8 T cells, which still express CD69 
  
45 
(Figure 3.2D). These results demonstrate that following stimulation aged splenocytes 
have an altered pattern of activation compared to young T cells, with a reduced ability to 
both increase the expression of CD25 and expand in response to ConA stimulation, as 
well as a delayed in CD69 down-regulation. These results confirm early studies which 
suggest that aged lymphocytes have a reduced ability to respond to non-specific 
stimulation in vitro (19).  
Treg cell percentage in young and aged mice 
We hypothesized that this reduced ability to respond to ConA stimulation could 
be due to an increased percentage of Treg cells found in aged mice. Splenocytes were 
isolated from young and aged mice and stained with antibodies that recognize Treg cells 
markers CD4, CD25 and intracellular foxp3. Aged mice have a significantly higher 
percentage of CD25+ CD4 T cells compared to young mice (young compared to aged, 
11.5% ± 1.2% compared 16.2% ± 1.5%, respectively; Figure 3.3A).  
Although the Treg cell percentage is increased in aged mice, there are no data 
available that would directly address whether or not this increased percentage of Treg 
cells interferes with the activation and expansion of T cells in response to ConA 
stimulation.  In order to evaluate if the reduced T cell response to ConA stimulation could 
be linked to the increased percentages of Treg cells, we evaluated the kinetics of Treg 
cells following ConA stimulation. Studies analyzing the function and presence of Treg 
cells in young mice suggest that although CD25 can be used as a marker of Treg cells 
prior to T cell stimulation, it cannot be used to identify Treg cells once T cells have been 
stimulated, due to the fact that following stimulation CD25 is quickly up-regulated on all 
T cells allowing them to bind growth cytokine IL-2 with high affinity (154). Therefore 
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foxp3 was used along with CD4 and CD25 to compare the percentages of Treg cells in 
young and aged mice.  Similar to the results comparing the percentage of CD25+ CD4 T 
cells, the assessment of CD4+CD25+foxp3+ T cells demonstrate that aged mice have an 
increased percentage of these cells as well. The percentage of Treg cells in aged mice was 
significantly increased compared to young mice at the initiation of culture (young 
compared to aged, 10.6% ± 0.5% compared 16.5% ± 1.1%, respectively; Figure 3.3A).  
While the percentage of Treg cells in aged remain higher than those in young mice 
throughout culture, both young and aged mice demonstrated a reduction in the percentage 
of Treg cells in vitro as early as 24 hours post stimulation (Figure 3.4). Further it appears 
that although the percentage of Treg cells decreases they still activate at similar levels in 
both young and aged mice, both quickly up-regulating the expression of CD69 and 
rapidly down-regulating the molecule (Figure 3.5).  
The results from these experiments prompted us to determine if Treg cells express 
higher percentages of Treg cells undergoing apoptosis. Isolated splenocytes were cultured 
with and without the apoptotic inducer camptothecin to determine if T cell subsets 
demonstrated differential susceptibility to apoptosis. Annexin V is a molecule found on 
the surface of nucleated cells which identifies early apoptotic event in the cell (156).  
Prior to treatment (Figure 3.6), CD4+CD25+ T cells have a high percentage of 
cells that already express Annexin V. CD4+CD25+ T cells of young and aged mice 
expressed similar percentages of cells that were Annexin V positive. Further following 
camptothecin treatment there were no difference in the susceptibility of Treg cells to 
undergo apoptosis as >75% of all T cell populations underwent apoptosis as 
demonstrated by the expression of Annexin V. Taken together the increased expression 
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of annexin V expression of CD4+CD25+ T cells prior to camptothecin treatment may 
suggest that some Treg cells are apoptotic upon isolation, but not more susceptible than 
other T cell populations. 
Depletion of CD4+CD25+ T cells in vitro  
 To address whether Treg cells interfere with in vitro activation and expansion of 
T cells, Treg cells were depleted from splenocytes of young and aged mice. Although 
foxp3 is the most definitive marker of Treg cells, the selection of Treg cells via foxp3 is 
impossible without genetic manipulation or destruction of the cells. Therefore CD25 was 
used as a target for selecting Treg cells from splenocyes. Depletion of Treg cells using 
MACS separation reduced the percentage of Treg cells in young splenocytes from ~8% 
to <2%, and the percentage of Treg cells in aged mice was reduced from 12% to <4% 
(data not shown). Although significant depletion of Treg cells was achieved prior to 
ConA stimulation, this depletion had a modest effect on 3H thymidine incorporation in 
young mice and no effect in aged mice (Figure 3.7A). Further this depletion appeared to 
have a similar and limited effect on CD8 T cell activation in vitro (Figure 3.7B).  
 
3.4 Discussion  
Age-associated decreases in immunity have been well documented in both rodents 
and humans. The most well studied and understood changes have been shown to be 
within the adaptive immune response, particularly T cell responses (40). A recently 
identified alteration within the immune system of aged mice is an increased percentage of 
Treg cells (63, 135). These Treg cells have been shown to exacerbate many diseases. In 
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particular Sharma et al. proposed that the increase percentage of Treg cells in aged mice 
interfere with the tumor immune response and hampers tumor rejection (134).  
The immune response involves a complex series of events that must occur for the 
efficient removal of foreign pathogens from the body. This complexity sometimes makes 
it difficult to study the age-altered changes in immunity during an in vivo immune 
response. In order to better analyze the differences in T cells in response to non-specific 
stimulation without the interference of other components of the immune response, 
lymphocytes were isolated from the spleens of young and aged mice and studied in vitro. 
We wanted to determine if reduced T cell activation and expansion was a result of the 
increased percentage of Treg cells in splenocytes of aged mice. We used the mitogenic 
stimulus ConA to stimulate splenocytes and study the activation and expansion of T cells 
and Treg cells in vitro.   
 Our initial results confirm previous reports which suggest that stimulation of 
lymphocytes of aged mice with a mitogenic stimulus results in a reduced capacity to 
expand compared to lymphocytes of young mice (47, 157, 158). Further we demonstrated 
that evaluating the expansion of T cells with 3H thymidine incorporation or CFSE yields 
similar results and correlate with one another (data not shown). T cells isolated from aged 
mice demonstrate a reduced capacity to be activated as shown by reduced percentages of 
T cells expressing CD25 and CD69. The activation of T cells from young mice exhibit a 
better ability to up-regulate the high affinity receptor CD25 compared to aged mice, who 
have a decreased percentage of CD25+ T cells. 
Young mice also demonstrate a better ability to quickly up-regulate CD69, 
followed by down-regulation of CD69 within 48 hours of stimulation, while aged mice 
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have an increased percentage of T cells that express CD69 following 48 hours of 
stimulation. These results may suggest that CD69 is a regulatory molecule involved in 
delaying the immune response. Recent findings demonstrate that a subpopulation of Treg 
cells constitutively express CD69 and are able to suppress the expansion of CD4 T cells 
in culture (137). Therefore in order for an immune response to proceed promptly CD69 
must be quickly down-regulated. CD69 may be necessary to protect from unwanted 
immune responses. T cells from aged mice express CD69 for a much longer period of 
time post stimulation as compared to aged mice.  These results may suggest a regulatory 
role for CD69 in aged mice. In addition this increased expression of CD69 by aged T 
cells may also contribute to reduced T cell expansion, therefore depletion of both Treg 
cells and CD69+ T cells may be necessary in order to enhance the in vitro response of 
splenocytes of aged mice to ConA stimulation.  
 We have confirmed other reports that suggest that the percentage of Treg cells in 
aged mice is significantly higher compared to the percentage found in young mice (63, 
133, 135, 159). Specifically we demonstrate that CD4+CD25+ T cells as well as 
CD4+CD25+foxp3+ are increased in aged mice. We have also shown that during 
stimulation while the percentage of Treg cells isolated from young mice is significantly 
reduced within 48 hours of stimulation, aged mice retain Treg cells until 72 hours of 
stimulation. This could be due to different mechanisms: 1) Efficient activation and 
expansion of T cells prompts the loss of Treg cells. The increased percentage of Treg 
cells at baseline in splenocytes isolated from aged mice may delay this removal. 2) The in 
vitro culture system doesn’t support the survival of Treg cells in vitro. It has been shown 
that Treg cells do not survive in the absence of IL-2 in vitro (160). Further it has been 
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proposed that the survival and maintenance of Treg cells in vivo is also dependent on 
proliferative cytokine IL-2 and in the absence of IL-2, such as the case in IL-2-/- mice, 
Treg cells are almost non-existent (109, 110, 133). Both phenomena are possible.  
The continued presence of Treg cells in unstimulated controls 24-96 hours after 
culture demonstrated that the in vitro culture conditions do support the continued survival 
of Treg cells in both young and aged T cells. However there is competition for IL-2 
between Treg cells and expanding T cells. Our results suggest that as effector T cells 
expand the percentage of Treg cells begins to decrease in both young and aged mice, due 
to the utilization of IL-2 by the effector cells. Although not evaluated in this report, it 
may be important to determine if following ConA stimulation if there are differences in 
the apoptosis of Treg cells isolated from young and aged mice and if addition of 
exogenous IL-2 prevents this decrease in Treg cells. 
From these results we hypothesized that depletion of Treg cells from splenocytes 
isolated from young and aged mice should enhance the activation and expansion of T 
cells. Although depletion of Treg cells did not enhance the activation and expansion of T 
cells from aged mice in vitro in response to non-specific stimulation to ConA, this does 
not rule out the possibility that the increased percentage of Treg cells does not interfere 
with in vivo immune responses to infection and tumors.  
We have demonstrated that sometimes there are no intrinsic changes within cells 
of aged mice, such as in dendritic cells isolated from aged mice which appear to have no 
decrease in their ability to prime CD8 T cells in vitro (19). The environment can be 
significantly altered with aging and this could be the case for Treg cells. Specifically we 
have demonstrated that adoptively transferred T cells from influenza TCR Tg mice 
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proliferate and respond well to infection in young mice whereas Tg cells fail to robustly 
respond to infection when adoptively transferred into aged mice (19). It has been also 
been demonstrated by several studies that Treg cells in aged mice are able to efficiently 
suppress T cell responses at levels comparable or higher than Treg cells from young mice 
(133, 134). Collectively this and other reports suggest that while the Treg cells may have 
a major impact on the environment of aged mice, this may not be due to intrinsic 
differences of Treg cells isolated from young and aged mice. The increase in the percent 
of Treg cells may be the major contributing factor. 
 This report confirms previous studies that aged mice have a reduced response to 
mitogenic stimulation with ConA as shown by reduced activation and expansion of both 
CD4 and CD8 T cells. Specifically it has been demonstrated that T cells from aged mice 
exhibit decreased levels of activation and rounds of replication (47). We also confirm that 
the percentage of Treg cells in aged mice is significantly higher. We propose that the role 
of Treg cells in aged mice should be explored within an in vivo system. One such system 
that offers us the ability to better understand the role of Treg cells in aging is the 
influenza model, as we and many other researchers have demonstrated a reduced immune 
response to influenza in both aged rodents and humans (161). Specifically, we have 
reported that aged mice have a reduced CD8 T cell response to influenza, and we 
hypothesize that Treg cells may contribute to this decrease expansion and function of 
CD8 T cells during influenza infection (61). This infection model could be used to 
evaluate the kinetics of Treg cells during influenza infection in vivo and the relationship 
of Treg cells to the reduced CD8 T cell responses in aged mice. Also depletion or 
addition of Treg cells prior to influenza in young and aged mice will allow us to 
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determine if the removal of Treg cells enhances the CD8 T cell response to influenza 
infection in aged mice and alternatively if the addition of Treg cells to young mice 
reduces the CD8 T cell response to influenza infection.  
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Figures and legends  
 
 
 
Figure 3.1 Expansion of lymphocytes isolated from young and aged mice following in 
vitro ConA stimulation: A) 3H thymidine incorporation of splenocytes from young ( ) 
and aged ( ) mice following 48 hours of in vitro stimulation with ConA. B) CFSE 
histograms of lymphocytes following conA stimulation at 24, 48, 72 and 96 hours post 
stimulation. Representative of 3 mice. C) Fold change in MFI. N=3 each age group and 
each time point. Experiments were repeated twice. Error bar represents the mean std 
error. *p<0.05, **p<0.01. 
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Figure 3.2. Activation of T cells following in vitro ConA stimulation:  The percentage of 
CD4+ or CD8+ T cells from young or aged mice expressing activation markers CD25 and 
CD69 was evaluated at 24, 48, 72 and 96 hours post stimulation with ConA, A) The 
percentage of CD4 T cells expressing CD25. B) The percentage of CD4 T cells 
expressing CD69. C) The percentage of CD8 T cells expressing CD25. D) The 
percentage of CD8 T cells expressing CD69. N=3 each age group and each time point. 
Experiment repeated twice. Error bar represents the mean std error. *p<0.05, **p<0.01. 
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Figure 3.3. Regulatory T cell percentage in young and aged mice: Splenocytes were 
isolated from young and aged mice and analyzed for the expression of CD25 on CD4 T 
cells at Day 0. N=3 each age group and each time point. Experiments repeated twice. 
Error bar represents the mean std error. *p<0.05, **p<0.01. 
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Figure 3.4. Regulatory T cell kinetics: Following ConA stimulation Treg cells kinetic 
was studied by staining ConA stimulated cells from young and aged mice with Treg cell 
markers, CD4, CD25 and foxp3 at various times. Unstimulated cell cultures were used as 
negative controls to compare the results with and without ConA stimulation. N=1 each 
age group and each time point. Experiment repeated twice. Error bar represents the mean 
std error. *p<0.05, **p<0.01. 
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Figure 3.5. Activation of Treg cells in young and aged mice following ConA stimulation. 
Treg cells (CD4, CD25 and foxp3) from young and aged mice were assessed for early 
activation marker CD69. N=1 each age group and each time point. Experiment repeated 
once. Error bar represents the mean std error. *p<0.05, **p<0.01. 
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Figure 3.6. Apoptosis of T cell subsets following treatment with apoptosis inducer 
camptothecin. CD4, CD8 and CD4+CD25+ T cells from both young and aged mice were 
stained with annexin V following 4-hours of incubation at 37oC with 5% CO2. N>3 each 
age group and each time point. Experiments repeated at least twice. Error bar represents 
the mean std error. *p<0.05, **p<0.01. 
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Figure 3.7. ConA stimulation of splenocytes of young and aged mice following depletion 
of Treg cells and with ConA. A) 3H thymidine incorporation of splenocytes from young 
and aged mice following Treg cell depletion and 48 hours of in vitro stimulation with 
ConA. The percentage of CD8+ T cells from young or aged mice expressing activation 
markers B) CD25 and C) CD69 was evaluated at 24, 48, and 72 hours post stimulation 
with ConA, in addition unstimulated controls were used as negative controls. N>3 each 
age group and each time point. Experiment repeated a least once. Error bar represents the 
mean std error. *p<0.05, **p<0.01. 
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Chapter Four: 
Expansion of Regulatory T Cells in Aged Mice following 
 Influenza Infection 
Yolanda Williams-Bey, Jiu Jiang and Donna M Murasko* 
Department of Biology, Drexel University 3141 Chestnut St, Philadelphia, PA 
Abstract 
 While it has been established that Treg cells can down-modulate an immune 
response, no study has addressed if the increase in Treg cells in aged mice is related to 
the decreased and delayed specific CD8 T cell responses seen following primary 
influenza infection. In this study, phenotypic characteristics and function of Treg cells 
were analyzed in young (4-6 months) and aged (18-22 months) mice prior to and during 
the course of primary influenza infection. Upon infection, aged, but not young, mice have 
a significant expansion of Treg cells. In addition, Treg cells of aged mice demonstrate 
both a higher percentage and higher expression per cell of CD69 both at baseline and 
during infection compared to young mice. However, Treg cells isolated from young and 
aged mice comparably suppress CD8 T cells and suppression is dose dependent. These 
results suggest that the increase in the percentage of Treg cells in aged mice may 
contribute to the diminished CD8 T cell response to primary influenza infection. 
 
4.1 Introduction  
Immunosenescence defines the decline in the immune response that occurs with 
aging. These changes have been associated with increased incidences of infection, 
malignancy and disease (162).While age-altered changes have been noted in almost every 
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component of the immune response: antigen presenting cells (APCs), B cells, T cells, as 
well as antibody and cytokine production (147), the most notable changes have been 
demonstrated in T cell responses (47, 163, 164). These deceases in T cell responses are 
observed both in vitro and in vivo. For example, our laboratory has demonstrated that 
following influenza infection aged mice have both a reduced and delayed response, 
measured by specific CD8 T cell expansion and IFN-γ production (61). While it is clear 
that aging negatively affects the immune response, the exact mechanisms of these 
changes are not well understood.  
Treg cells are a subpopulation of T cells which are responsible for maintaining 
immunological self-tolerance and reducing tissue damage following an immune response 
(46). Sakaguchi et al. demonstrated that a subpopulation of CD4 T cells constitutively 
expresses the IL-2Rα chain (CD25) and that these cells demonstrate suppressive 
capabilities (79). However, since all lymphocytes have the ability to up-regulate CD25 
following activation, in order to bind growth cytokine IL-2 with high affinity, this marker 
alone cannot be used to identify Treg cells. Foxp3 (Forkhead winged helix protein 3) is 
an intracellular molecule expressed solely by Treg cells. Foxp3 is required for the 
development and function of Treg cells and absence of this molecule either by genetic 
defect, molecular manipulation or selective depletion results in the absence of Treg cells 
(81, 84, 100). The importance of foxp3 in Treg cell function is demonstrated in scurfy 
mice and its human related IPEX (immune dysregulation, polyendocrinopathy, 
entropathy, X-linked) syndrome. These diseases have both been linked to genetic 
mutation in the protein coding for foxp3. Scurfy mice and IPEX patients suffer from 
multi-organ lymphoproliferative disorder and usually die early in life. While the 
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importance of Treg cells in maintaining immunological tolerance to self cannot be 
minimized, the mechanisms used to exert tolerance may interfere with a response to 
foreign antigen (165, 166).  
Treg cell percentage and number have been shown to increase with aging (63, 
135). It has been postulated that the accumulation of fully functional Tregs in aged mice 
diminishes the ability of aged mice to mount a robust immune response. Lages et al. 
demonstrated that Treg cells from aged mice suppress the production of IFN-γ by effector 
T cells during Leishmania major infection and that depletion of Tregs prevents 
reactivation of the infection (133). Similar studies have demonstrated that Treg cells can 
reduce tumor immunity in aged mice (134). These studies collectively demonstrate that 
Treg cells may contribute to immunosenescence and discerning their function may lead to 
a better understanding of the decline in T cell responses seen in aging.  
While the phenotype of Treg cells in aged mice has been analyzed in several 
studies using both in vitro and in vivo systems, no study has addressed whether or not 
Treg cells play a role in the reduced response to primary virus infection that is seen in 
aging. In the current study, we investigated possible phenotypic differences in Treg cells 
of aged mice before and after influenza infection to determine if such changes influence 
the CD8 effector T cell response to primary virus infection. Since the assessment of 
functional capacity of Treg cells of aged mice has produced conflicting results (79, 133, 
134), we wanted to examine further the functional capacity of Treg cells isolated from 
young and aged mice. The results of these studies not only confirmed that there is a 
significant increase in Treg cells in aged mice, but also that the percentage of Treg cells 
increases further after infection in aged but not young mice. In contrast, there is no 
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difference in the suppressive abilities of Treg cells isolated from young and aged mice. 
Our findings suggest that this increase in Treg cells in aged mice may interfere with the 
primary immune response to influenza.  
 
4.2 Methods and Materials 
Mice 
Four-month and 18-month old wild type Balb/c and C57Bl/6 mice were purchased from 
the NIA at Harlan Sprague Dawley (Indianapolis, IN). Six to 8 week old P14 (GP33-41 
TCR-Tg) mice (Ashton-Rickardt et al, 1994) were purchased from Taconic Farms 
(Hudson, NY), and 6 to 8 week old Balb/c ByJ Cl.1 Thy1.1, Clone-4 (HA518-526 TCR-Tg) 
mice (Cl-4) (Kreuwel et al., 2001) were purchased from Jackson laboratory (Bar Harbor, 
Maine). All mice were maintained in AAALAC-approved barrier facilities at Drexel 
University (Philadelphia, PA). Mice were allowed to acclimate for at least one week in 
our animal facilities prior to use. Mice exhibiting enlarged spleens or tumors were 
eliminated from this study. All experiments involving mice were conducted with the 
approval of the Institutional Animal Care and Use Committee (IACUC) of Drexel 
University.  
Virus Infection 
Influenza A-Puerto Rico/8/34 (PR8; H1N1) viruse was propagated in specific-pathogen-
free eggs and stored at -80 oC for subsequent use. Mice were infected intravenously (i.v.) 
with 300 ul of sterile saline containing 300 Hemagglutination units (HAU) of PR8.  
Ex-vivo stimulation  
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Splenocytes were isolated from young and aged mice using 0.83% ammonium chloride 
and resuspended in RPMI-1640 containing 10% FB, L-glutamine, 2-b-mercaptoethanol 
and gentamycin. Splenocytes were stimulated with 10-6 M NP366-374 peptide for influenza 
infected C57Bl/6 mice or 10-6 M HA518-522 peptide for influenza infected Balb/c mice and 
stimulated for 5 hours at 37 oC with 5% CO2 . Following surface and intracellular 
staining, cells were analyzed using flow cytometry. 
Treg Isolation 
Isolated splenocytes were resuspended in MACS buffer (PBS, 0.5%BSA) and stained 
with an antibody cocktail, which recognizes CD8, CDc11 and NK1.1 and micro-beads, to 
negatively select for CD4+T cells. Following CD4 selection, remaining splenocytes are 
stained with an antibody which recognize CD25 and micro-beads. The double selection 
method allows for the selection of cells, which are postive for both CD4 and CD25. 
Suppression Assay 
Responder cells were isolated from TCR Tg mice and labeled with the cytoplasmic dye 
CFSE. 1.5x105 total TCR Tg splenocytes per well were co-cultured with Tregs at a Treg 
cell: Tg splenocyte ratio of either 1:1 or 1:10 in a 96-well plate containing 10-6 M of 
GP33-41 peptide for responder cells from P14 mice or HA518-526 for responder cells from 
Cl-4 mice. Plates were incubated for 72 hours at 37oC with 5% CO2. Percentage of 
CFSElo CD8 T cells were obtained by gating on CD8 T cells as the parent population 
then gating on all CD8 T cells with an CFSE MFI <103. 
Flow Cytometry 
2x106 cells were stained for surface markers using mAb (anti-CD4, CD8, CD44, CD62L, 
CD69, CD25 and CTLA-4) purchased from BD Pharmigen. Intracellular staining was 
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performed using anti-foxp3 mAb purchased from Ebioscience following fixation wash 
buffers (cytofix and cytoperm kit purchased from Ebioscience). Intracellular IFN-γ 
antibody was purchased from BD Pharmingen; cells were fixed with fixation buffer 
purchased from BD. Flow cytometry was performed on FACS Canto and data was 
analyzed using FlowJo Software. 
Statistical Analysis 
All statistical analyses were performed using Student’s t test. Significant differences were 
determined at the level of p < 0.05. Results are expressed as mean ± SD. Correlation was 
calculated using excel and pearson’s correlation coefficient.  
 
4.3 Results 
Expansion of CD4+foxp3+ and CD4+CD25+foxp3+ T cells in response to PR8 virus 
infection in vivo.  
 We have previously demonstrated that aged mice have a delayed and reduced 
CD8 T cell response to influenza infection (61). To examine the possible contribution of 
Treg cells to this change, young and aged B6 mice were infected with 300 H.A.U. of PR8 
influenza virus. Splenocytes were obtained at varying times after infection and stained 
with antibodies that recognize Treg cells as well as specific CD8 T cells. While there was 
no significant change in the percentage of CD4+CD25+foxp3+ or CD4+foxp3+ T cells in 
young mice following infection, significant expansion of Treg cells was observed in aged 
mice (Figure 4.1A and B) . Notably at the peak of both specific CD8 T cells (NP366-374) 
expansion (Figure 4.1C) and function (IFN-γ) (Figure 4.1D) in young mice (Day 7), aged 
mice demonstrated the peak expansion of Treg cells and limited specific CD8 T cell 
response. Interestingly the percentage of Treg cells returned to pre-infection levels in 
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aged mice on day 10, the time at which significant expansion of specific CD8 T cells and 
IFN-γ production is observed in aged mice. These results suggest that the decrease in 
specific CD8 T cell expansion and function in aged mice may be related to the increased 
number and percentage of Treg cells not only at baseline but also the expanded 
percentage after viral infection.  
We also investigated whether or not the Treg cells were more activated by 
assessing both the percentage and level of expression of CD69 following influenza 
infection. Although CD69 has been recently described as a possible regulatory marker 
(137), CD69 is also a marker of activation in response to antigen challenge (167). Our 
previous data demonstrated that CD69 activation occurs early usually peaking during the 
first 24 hours after infection on CD8 T cells (data not shown). Analysis of Treg activation 
revealed that CD4+foxp3+ Treg cells in aged mice demonstrate a significantly increased 
percentage of CD69 expression at baseline compared to Treg cells of young mice and 
infection further significantly increases the percentage of CD4+foxp3+ Treg cells of aged, 
but not young mice, that express CD69 (Figure 4.2A). This increase is apparent not only 
in the percent positive but also in the level of expression of CD69 as determined by MFI 
which is also significantly higher at baseline in aged mice and increases following 
influenza infection (Figure 4.2B).  
 
Phenotypic characteristics of Treg cells in aged compared to young mice.  
To further explore whether or not Treg cells play a role in the reduced immune 
response to viral infection of aged mice, we wanted to characterize the Treg cells seen 
both at baseline and after infection.  While a number of studies on Treg cells and aging 
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report increased percentages, we also wanted to study other markers implicated in the 
function of Treg cells, which have not been well characterized in aged mice. 
Many studies examining Treg cells identify Treg cells as CD4+CD25+ T cells 
(79). Our data confirm previous studies demonstrating that aged mice have a significant 
increase in this population (Figure 4.3A: young vs. aged 11.6 ± 1.2% vs. 16.2 ± 1.5% 
p<0.05). Co-expression of both CD25 and foxp3 on CD4 T cells has also been used to 
define Treg cells (63). Analysis using these two markers demonstrated a similar increase 
of Treg cells in aged compared to young mice (Figure 4.3C: young vs. aged 10.6 ± 0.5% 
vs. 16.5 ± 1.1% p<0.001). However, we observed the largest difference between young 
and aged mice in the percentage of CD4+foxp3+ T cells (Figure 4.3B: young vs. aged 
14.3 ± 0.5% vs. 24.4 ± 0.8% p<0.001). 
Several surface receptors of Treg cells have been implicated in the down-
regulation of activated T cells. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) is expressed 
by a subpopulation of T cells and has been shown to negatively affect the immune 
response. When CTLA-4 is deleted or blocked by antibody, mice have been reported to 
develop autoimmunity (138) or to exhibit enhanced tumor immunity (168). We found no 
statistical difference between young and aged mice in the percentage of CD4 T cells that 
expressed CTLA-4 (Figure 4.2D).  
It has been reported that Treg cells constitutively express Glucocorticoid-induced 
TNF-related receptor (GITR). However the importance of this receptor in Treg cells 
function is questionable. While addition of anti-GITR completely abrogates suppression, 
the mechanism of inhibition by this molecule remains controversial (139). Further, 
CD4+CD25+ Treg cells from GITR-/- mice are able to suppress CD4 effector T cells at 
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levels similar to Treg cells isolated from GITR+/+ (169). The proportion of CD4 T cells 
expressing GITR is significantly increased in aged mice (Figure 4.3E: young vs aged 
15.8 ± 2.0% vs 32.0 ± 2.7% p<0.001) and most closely reflects the percentage of 
CD4+foxp3+. 
CD69 is recognized as an early activation marker. Recently Han et al. have 
demonstrated that a sub-population of CD4 T cells which constitutively express CD69 
have regulatory capabilities (137). These cells do not express CD25 or foxp3 and 
therefore were proposed as a new subset of Treg cells. We found that aged mice have an 
increased proportion of CD4+CD69+ T cells compared to young mice, (Figure 4.3F: 22.5 
± 3.7% vs. 8.6  ± 1.5%, respectively, p<0.01).   
Since many of the markers used to identify Treg cells are molecules that may be 
involved in their function, we also assessed age-associated differences in the levels of 
expression of these molecules using mean fluorescence intensity (MFI) (Figure 4.4 and 
Table 4.1). Traditionally it has been acknowledged that CD25 is a marker of Treg cells. 
However, CD25 is also up-regulated on activated T cells. Similarly CD69, CTLA-4 and 
GITR are all increased on T cells upon activation. In contrast foxp3 protein is found only 
in Treg cells. Therefore we defined Treg cells as CD4+foxp3+ T cells and examined the 
expression of activation markers on these cells.  
Treg cells of young and aged mice express foxp3 and CTLA-4 at similar levels. 
CD25 (IL-2Rα), believed to interfere with effector T cells binding to the proliferative 
cytokine IL-2, demonstrate an increased expression on Treg cells of young mice 
compared to their older counterparts (450 ± 78.2 vs 206 ± 32 p<0.05). In contrast, the 
expression of CD69 is significantly decreased in young compared to aged mice.  
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The migration of Treg cells can have a significant impact on function in vivo. 
Similar to effector T cells, Treg cells express CD62L which could play an important role 
in Treg trafficking. Treg cells of aged mice demonstrated a significant reduction in 
CD62L expression compared to young mice, 147 ± 13.6 vs. 307 ± 6.2 (p<0.01). CD44 
marker has also been implicated as a marker on Treg cells (170); no differences were 
noticed between Treg cells of young vs aged mice. While the percentage of Treg cells 
(4+25+) were significantly increased in aged compared to young mice; aged mice had 
significantly decreased expression of CD25 compared to young mice. In contrast the aged 
mice had significantly increased expression of CD69, GITR and CD62L. Other important 
Treg cell functional markers, CD44, foxp3 and CTLA-4, showed no age-altered 
difference in their expression patterns.  
 
CD4+CD25+ Treg cells from young and aged mice suppress specific Tg splenocytes at 
similar levels.  
 Our results demonstrate that influenza infection of aged mice induces an increase 
in the percentages of Tregs. However, since there are conflicting studies regarding 
whether or not Treg cells isolated from young and aged mice suppress T cells at a similar 
level (133, 134), we wanted to examine the ability of Treg cells from aged mice were 
able to suppress specific CD8 T cell responses. We addressed this question using an in 
vitro suppression assay.  
 While foxp3 is the only molecule uniquely expressed on Treg cells, its 
intracellular location makes it impossible to utilize to sort cells. Thus the CD25 surface 
receptor is commonly used to isolate Treg cells. CD4+CD25+ were isolated from young 
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and old B6 mice. Splenocytes from TCR Tg mice were used as responder cells. Ideally 
we would have used a Tg mouse model whose TCR recognize influenza antigen on a B6 
background. However since such mice are not commercially available, we utilized B6 
mice recognizing LCMV (P14). CD4+CD25+ Treg cells were co-cultured with isolated Tg 
splenocytes labeled with CFSE at Treg cell:Tg splenocytes ratios of 1:1 and 1:10 and 
then stimulated with GP33-41 peptide. 72 hours post stimulation co-cultures were stained 
with antibodies that recognize CD8 T cell activation (CD25) and assessed for the 
expansion and activation of CD8 T cells. As shown in Figure 4.5, addition of Treg cells 
from young and aged mice significantly suppress specific CD8 T cell responses at similar 
levels. Specifically the addition of Treg cells significantly reduces the expansion of 
specific CD8 T cells, demonstrated by increased CFSE expression in co-cultures 
containing Treg cells. Further the addition of Treg cells significantly reduced the 
percentage of CD8 T cells which express activation marker CD25. Addition of Treg cells 
at a ratio of 1:10 did not have a significant impact of CD 8 T cell expansion.  
While influenza specific Tg mice are not available on a B6 background they are 
available on a Balb/c background (Clone-4 (CL-4)). Since several studies have reported 
differences in the function of Treg cells isolated from different mice strains (171), it was 
important to determine whether are not the similarities seen in Treg cell function in 
young and aged mice is a strain dependent phenomena. In addition we wanted to ensure 
that these results were not unique for P14 Tg mice or LCMV suppression. Therefore 
suppression of influenza specific Tg splenocytes was also evaluated using Treg cells from 
young and aged Balb/c mice. CL-4 influenza specific Tg splenocytes respond to 
influenza peptide HA518-526. Experiments using CL-4 Tg mice had similar results 
  
71 
confirming that Treg cells from young and aged mice suppress specific CD8 T cells at 
similar levels (Figure 6.2).  
We further analyzed the dose dependency of Treg cells by comparing the 
activation of P14 CD8 T cells in the presence of CD4+foxp3+ Treg cells. Correlation 
between the percentages of CD4+foxp3+ T cells with activated CD8+CD25+ T cells in the 
culture suggests that activation of CD8 T cells is inversely related to the percentage of 
Treg cells (Correlation co-efficient of 0.936 vs. 0.852, young vs. aged respectively, 
p<0.01; Figure 4.6A). We were observed that CL-4 Tg cells were similarly suppressed in 
a dose dependent manner (Figure 4.6B).  
The results from these experiment further support the hypothesis that Treg cells 
isolated from young and aged mice suppress at similar levels (134). The individual 
function of aged Treg cells may not be a major factor in the reduced immune response 
however the increased percentages of Treg cells found in aged mice could be a potential 
barrier for the specific CD 8 T cell response.  
 
4.4 Discussion  
 Po et al. demonstrate that the specific CD8 T cell response to primary influenza 
infection is altered in aged mice, as shown by decreased and delayed CD8 T cell 
expansion as well as specific CD8 T cell function as assessed by IFN-γ production (61). 
While many studies link the age-altered changes in T cells to intrinsic defects, we 
hypothesized that the extrinsic environment of aged mice may also contribute to the 
decrease. Specifically we hypothesized that this decreased CD8 T cell expansion and 
function may be linked to the increase in Treg cells seen in aged mice.  
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Since Treg cell percentage is increased in aged mice (172), we wanted to study 
the effects of influenza infection on this population of CD4 T cells. As early as 5 days 
after infection we see a significant increase in the percentage of Treg cells in aged mice 
while young mice maintain a similar percentage of Treg cells throughout the course of 
infection (Figure 4.1). The expansion of Treg cells in aged mice could provide a potential 
hurdle for the immune response to overcome, as other studies have demonstrated Treg 
cells can interfere with the in vivo immune response (151). It is not until day 10 when the 
percentage of Treg cells in aged mice returns to basal level that the CD8 T cells begin to 
expand and respond to influenza infection by producing IFN-γ. Interestingly after 
influenza infection, Treg cells have an increase state of activation as demonstrated by 
increasing percentages and increased expression of CD69 both before and during 
infection. We hypothesize that this early and continued expansion of Treg cells in aged 
mice may interfere with expansion and function of specific CD8 T cell. 
Several studies have compared the percentages of Treg cells. As previously 
discussed Treg cells have been defined differently based on their surface phenotype as 
being: CD4+CD25+, CD4+foxp3+ or CD4+CD25+foxp3+. In this report we are able to 
conclude that Treg cells are significantly increased in aged (>18 months) compared to 
young (4-6 months) mice in all three of the previously defined populations (Figure 1). 
Following the proposal of a new subset of Treg cells, CD4+CD69+ Treg cells, we also 
examined this subpopulation of CD4 T cells. Han et al. demonstrated that similar to the 
before mentioned Treg cells these cells were also able to suppress effector T cell function 
(137). We found that total CD4+CD69+ T cells as well as CD4+CD69+foxp3- Treg cells 
are also increased in aged mice compared to young (young vs aged, 8.9 ± 1.6% vs 19.4 ± 
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2.3%). These results provide an interesting set of data, which shows that the regulatory 
component of the immune response is significantly changed in aging.  
 The function of Treg cells may be important in discerning if they contribute to the 
age-associated decrease in the immune response. Their presence alone may or may not be 
sufficient enough to effect the immune response. It is the active suppression of effector 
cells which interfere with an active immune response. Our results from in vitro 
suppression assays agree with those of Sharma et al. and Nishioka et al. which suggest 
that there is no difference in per cell function in aged Treg cells (63, 134). In addition, we 
show that Treg cells suppress CD8 T cell activation in a dose dependent manner (figure 
8). The dose dependent suppression of effector function, demonstrated by the significant 
R2 values seen in correlation studies, is critical when there is increasing percentages 
found in aged mice both prior to and during and immune response to influenza infection. 
This increased percentage of Treg cells may raise the threshold of activation required to 
produce a strong immune response to foreign antigen.  
Although we report here no significant difference in the suppressive function of 
Treg cells in a suppression assay, our results from MFI shows that aged mice have an 
increase expression of GITR, whose ligand is found on APCs. The GITR ligand usually 
binds to T cells during an immune response and this binding enhances antigen 
presentation as well as activation of APCs and T cells. The constitutive expression of 
GITR on Treg cells allows them to bind to APCs as well and interfere with antigen 
presentation and T cell activation. It has been reported that G3c, a mAb which recognizes 
GITR, breaks the hypoproliferative state of Treg cells and cause them to expand both in 
vivo and in vitro (172). Therefore we postulate that binding of Treg cells to APCs via 
  
74 
GITR can both down-regulate an immune response by interfering with antigen 
presentation and can also lead to the expansion of Treg cells. GITR should be further 
analyzed as a mechanism, which leads to the expansion of Treg cells following influenza 
infection in aged mice.  
Taken together we believe the overall presence of increasing percentages of 
activated Treg cells in aged mice is a contributing factor in the decreased and delayed 
CD8 T cell during primary influenza infection.  
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Figure and Table Legends 
 
 
Figure 4.1. Expansion of Treg cells in response to influenza infection. Young and Aged B6 
mice were i.v. infected with 300 H.A.U PR8. On Days 5, 7 and 10 post-infection, splenocytes 
were isolated, stained with CD4, CD25 and foxp3 antibodies and for virus specific CD8 cells 
with NP366-374 and IFN-γ and assessed by flow cytometry A) Percentage of CD4 T cells that 
are CD25 and foxp3 positive. B) Percentage of CD4 T cells positive for foxp3. C) Percentage 
of CD8 T cells positive for NP366. D) Percentage of CD8 T cells positive for IFN-γ. Values 
represent the mean of ± S.E., n=6 per day per age group. *p<0.05, **p<0.01, ***p<0.001 
compared to Day 0. # p<0.05 comparing young and aged in same day. 2 independent 
experiments combined.  
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Figure 4.2. Activation of Treg cells in response to influenza infection. On Days 5, 7 and 
10 post-infection, CD4+foxp3+ Treg cells were analyzed by flow cytometry for 
expression of activation marker CD69. Data represents the mean ± S.E., n=3 mice per 
day per group. *p<0.05, **p<0.01, ***p<0.001 comparing responses to uninfected of 
same age. #p<0.05, ##p<0.01, ###p<0.001 comparing the responses of young vs aged on 
same day. Two experiments combined. 
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Figure 4.3. Characterization of CD4 T cells in the spleens of young and aged mice. 
Splenocytes were isolated from young and aged C57BL/6 mice then stained with 
antibodies associated with Treg cells (CD4, CD25 and foxp3) and assessed by flow 
cytometry. Values represent the mean ± S.E., n=7 - 30 mice per group. *p<0.05, 
**p<0.01, ***p<0.001.  
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Figure 4.4. Expression of Treg cell markers of young vs aged mice. CD4+foxp3+ Treg 
cells were analyzed for their expression of surface receptors related to their function. All 
CD4 cells expressing foxp3 were analyzed for their expression of foxp3, CD25, CTLA-4, 
GITR, CD69, CD44 and CD62L. Representative experiment repeated twice.  
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Table 4.1.  Mean fluorescent intensity of functional markers on CD4+foxp3+ Treg cells. 
CD4+foxp3+ were analyzed for there expression of CD25, foxp3, CTLA-4, GITR, CD44 
and CD62L. Experiment repeated twice with three mice comparing young and aged mice 
in each experiment. a: p<0.05, b: p<0.001 
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Figure 4.5. Young and aged Treg cells of mice suppress Tg splenocytes at similar levels. 
CD4+CD25+ Treg cells were isolated from young and aged B6 mice and co-cultured  with 
Tg splenocytes at a ratio of 1:1 or 1:10 (Treg cell;Tg splenocyte). A) Histogram 
representation of Tg splenocytes stimulated in the absence and presence of young or aged 
enriched CD4+CD25+ cells. B) Bar graph representative of CD8 T cell expansion 
assessed by CFSE and C) activation assessed by percent CD25 expression. Data 
represents the mean ± S.E., n=3. Similar results were obtained in two experiments.  
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Figure 4.6.  Correlation between CD4+foxp3+ Treg cells and activated CD8+CD25+ T 
cells.  Following 72 hours of stimulation co-cultures were stained with antibodies that 
recognize Treg cells and CD25+ CD8 T cells. Results from B6 and P14 co-cultures. Data 
represents n=6 per age group. Results were obtained in two similar experiments.  
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Chapter Five: General Discussion 
 
It has been reported by many that aging is associated with increase incidences of 
infection, as well as increased morbidity and mortality. Po et al. demonstrated that aged 
mice have a delayed and decreased CD8 T cell response to influenza infection (61). This 
alteration in the CD8 T cell response may be due to increased percentages and numbers 
of Treg cells found in aged mice (63). No study has addressed the possible role of Treg 
cells in the reduced primary immune response seen in aging following influenza 
infection. The goal of this project is to determine if the increased percentage of Treg cells 
in aged mice contribute to the decreased and delayed CD8 T cell response following 
influenza infection in aged mice. 
Initially we wanted to determine if the increased percentages of Treg cells in aged 
mice contributed to the reduced T cell response in vitro to ConA stimulation. Numerous 
studies have reported that upon ConA stimulation lymphocyte expansion is reduced in 
aged mice compared to young mice, however no study has evaluated the possible role of 
Treg cells in this reduction (47). Although many studies are beginning to compare the 
function and phenotype of Treg cells from young and aged mice both in vitro and in vivo 
(63, 133-135), no studies have identified a simple and reproducible way to detect the 
activation of these cells. It has been demonstrated by several studies that the activation of 
Treg cells is necessary for suppression to take place both in vitro and in vivo (122,173).  
Billiard et al. has demonstrated that in vivo immune regulation, specifically suppression 
of effector T cells, is dependent upon Treg cell activation (173). These studies assessed 
activation of Treg cells by proliferation or the increased expression (percentage or MFI) 
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of a marker constitutively expressed by Treg cells such as CD25 or foxp3. Thorton et al. 
assessed the activation of Treg cells based on their ability to suppress responder T cells 
(122). In order to address the overall objective for this project we needed to identify a 
reliable marker to detect the activation of Treg cells. In addition we also wanted to 
evaluate the contribution of Treg cells to the decreased T cell response of aged mice in 
vitro. We hypothesized that the decrease in activation and expansion of lymphocytes 
from aged mice could be a result of the increased percentage of Tregs.  
Although traditionally it has been accepted that Treg cells co-express both CD4 
and CD25, identification of Treg cells following in vitro stimulation or in vivo infection 
makes it impossible to differentiate Treg cells from recently activated CD4 T cells due to 
up-regulation of CD25 on activated cells. Therefore we relied more heavily on the unique 
expression of transcription repressor foxp3 in Treg cells for identification of Treg cells.  
However to allow for comparison to previous studies we evaluated expression of both 
CD25 and foxp3 on resting CD4 cells. Evaluation of CD25 and foxp3 demonstrated that 
CD4 T cells from aged mice had a higher percentage of CD4+CD25+, CD4+CD25+foxp3+ 
and CD4+foxp3+. Although we found significant increases of Treg cells in aged mice 
using all combinations of Treg cell markers, we observed that the largest change in Treg 
cell percentage was seen within the CD4+foxp3+ population. This is interesting since 
foxp3 is the only unique marker for Treg cells. It has also been demonstrated that aged 
mice have increased incidence of inflammation (174); this report and others propose that 
T cells in aged mice may be in a state of activation even when there is no obvious foreign 
pathogen. This inflammation can lead to the presence of increasing percentages and 
numbers of recently activated CD4+CD25+ T cells. One might have postulated that the 
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largest difference between young and aged mice would have been in CD4+CD25+ since 
some of these cells would be activated cells, not Treg cells. Our results, however, support 
a previous study which demonstrated that not all Treg cells in aged mice express CD25 
(63).  
 Having confirmed this increased percentage of Treg cells in aged mice, we then 
determined the response of Treg cells to in vitro stimulation with ConA. This experiment 
demonstrated that similar to other T cell populations Treg cells could respond to 
mitogenic stimulation, which was demonstrated by the up-regulation of early activation 
marker CD69. This result also demonstrated that Treg cells in young and aged mice were 
activated similarly with no significant differences in the peak of total CD69 expression. 
Further the kinetics of expression was similar with Treg cells from both groups reaching 
its peak CD69 MFI approximately 24 hours post ConA stimulation. The data from this 
section collectively demonstrate that there is an increased percentage of Treg cells in 
aged mice, using 3 independent but complementary cell markers. Further it demonstrates 
that early activation marker CD69 can be used to identify their activation.  
 It appeared that following Treg cell activation the percentage of Treg cells in 
culture begins to decrease in both young and aged mice. We hypothesized that this 
decrease in Treg cells is a result of cytokine deprivation, mainly IL-2. A mechanism of 
Treg cell suppression has been proposed to be competition of IL-2 being produced by 
effector cells (108). With the expanding presence of CD25hi T cells which are binding IL-
2 there is minimal cytokine available for Treg cells. It has also been demonstrated by 
Pandiyan that Treg cells need IL-2 for continued survival in vitro. In this study 
CD4+CD25+ T cells cultured alone without IL-2 producing effector T cells leads to 
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apoptosis of the cells. However when IL-2 is added back to the culture in small doses or 
when CD4+CD25+ T cells are cultured with stimulated CD4 T cells, survival of Treg cells 
is enhanced (160). This need for IL-2 may be an internal mechanism that supports the 
survival of either Treg cells or T cells.  Prior to T cell expansion and activation Treg cells 
are able to absorb IL-2 being secreted via the constitutively expressed complete IL-2R; 
however once activated T cells expand and compete for IL-2 with Treg cells, expanded T 
cells consume most of the IL-2 in culture leading to deprivation and death of Treg cells. 
The rate of decline in young and aged mice is similar, however, the increased percentages 
of Treg cells in aged mice may contribute to the delayed response or early stopage due to 
competition in the environment of decreased IL-2 production by aged T cells. Although 
we did not directly address the level of apoptosis during ConA stimulation, induction of 
apoptosis with camptothecin demonstrated no significance difference in the expression of 
the apoptotic marker annexin V between young and aged mice, suggesting a similar 
sensitivity of Treg cells from young and aged mice to apoptosis. 
This need for IL-2 may be a safety mechanism to protect the host from auto-
immunity. Small amounts of IL-2 may be secreted during the resting phase. The 
constitutive expression of IL-2R allows Treg cells to bind this IL-2 in order to avoid an 
immune response. However in cases where large amount of IL-2 is produced, Treg cell 
suppression can be overcome. Incidental activation of the immune response could be 
potentially damaging to the host, causing excess tissue damage and inflammation, which 
could potentially lead to autoimmunity.  
 Finally although the removal of Treg cells from aged T cells prior to ConA 
stimulation had no effect on T cell activation and expansion, this could be due to the 
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depletion of non-Treg cells. As discussed earlier all CD4+CD25+ T cells are not Treg 
cells, while only ~70% of CD4+CD25+ T cells in aged mice are foxp3+ greater than 90% 
CD4+CD25+ T cells are foxp3+ in young T cells. However the internal location of foxp3 
makes it impossible for use to select cells based on that marker. As better experimental 
techniques are developed which will allow for more specific selection of Treg cells this 
topic should be revisited.  
   In addition to confirming the increased percentage of Treg cells in aged mice 
and evaluation of the response of Treg cells to in vitro ConA stimulation we wanted to 
compare the function of Treg cells isolated from young and aged mice. Specifically we 
wanted to determine if Treg cells from young and aged mice could suppress specific CD8 
T cell expansion and activation at comparable levels. This experiment was important 
since there continues to be debate about the function of Treg cells isolated from young 
versus aged mice. Initially Nishioka et al. demonstrated that the suppressive ability of 
Treg cells isolated from aged mice suppressed the proliferation of responder CD4 T cells 
at levels similar to those isolated from young mice (63). Sharma et al. demonstrated 
similar results that CD4+CD25+ Treg cells from aged mice were able to suppress CD8 T 
cell tumor responses at levels similar to CD4+CD25+ Treg cells from young mice (134). 
In contrast the studies of Lages et al. demonstrated that Treg cells isolated from GFP-
foxp3 knock-in aged mice were more suppressive than those isolated from GFP-foxp3 
knock-in young mice on a per cell basis (133). Therefore, we wanted to determine that in 
addition to the increased percentage of Treg cells in aged mice if there is also increased 
function of Treg cells from aged miced. 
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To address the function of Treg cells from young versus aged mice we used a 
transgenic mouse model. Lymphocytic Choriomeningitis Virus (LCMV) transgenic mice 
on a B6 background, P14 mice, whose T cells express a transgenic TCR which only 
respond to LCMV antigen GP33-41. Using splenocytes from TCR Tg mice allow 
assessment of the suppression of specific T cells. Treg cell suppression has been 
demonstrated to be non-specific and Treg cells are able to suppress the expansion and 
function of specific CD8 T cells both in vitro and in vivo (166, 175). Initial experiments 
for this project used B6 mice, because our early findings that confirmed increased 
percentages of Treg cells in aged mice as well as the delayed and decreased CD8 T cell 
response following influenza infection were performed using young and aged mice on a 
B6 background. Further while we use influenza virus as an infection model, there are no 
such B6 mice commercially available whose TCR expresses influenza. Splenocytes from 
Tg mice were cultured with freshly isolated CD4+CD25+ T cells at a ratio of Treg cells: 
splenocytes of 1:1 and 1:10. At a ratio of 1:10 there was limited suppression of 
splenocytes using either CD4+CD25+ T cells from young or aged mice. At ratios of 1:1 
there was significant suppression of specific CD8 T cells, however there was no 
significant difference between the suppression of specific CD8 T cells using Treg cells 
from young or aged mice. These results are in accordance with Sharma et al. and 
Nishioka, which both report no difference in suppression of Treg cells isolated from 
young or aged mice (63, 134).  
Although there are no influenza specific TCR Tg mice available on a C57BL/6 
background, there are Balb/c Tg mice Cl-4 whose TCR is specific for influenza antigen 
HA518-526. Experiments conducted using Cl-4 mice yielded similar results with no 
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suppression occurring at ratios of 1:10 and similar suppression seen at ratio 1:1 when 
using young or aged CD4+CD25+ T cells. Further the results from both experiments 
demonstrated that suppression of specific CD8 T cells occurred in a dose dependent 
manner, with both young and aged mice demonstrating a significant inverse correlation 
between the percentage of CD4+foxp3+ Treg cells and activation of specific CD8 T cells. 
Taken together we concluded that there was no difference in the ability of Treg cells, 
from young and aged mice, to suppress CD8 T cell responses.  
In addition to evaluating the ability of isolated Treg cells from young and aged 
mice to suppress specific CD8 T cell expansion in vitro in response to specific peptide, 
we evaluated the expression of Treg cells functional markers at baseline to determine if 
there were any differences between Treg cells from young and aged mice. There was 
differential expression of various markers. Foxp3 expression was similar in CD4+foxp3+ 
T cells from young and aged mice. While there was no difference in foxp3 MFI, CD25 
MFI was increased in young compared to aged Treg cells while GITR MFI was 
decreased. It is generally accepted that CD25 is necessary for the high affinity binding of 
IL-2 to effector cells. In Treg cell function it has also been shown that Treg cells bind IL-
2 through CD25. The lower expression suggests that Treg cells of aged mice would not 
compete as successfully with the antigen-reactive T cell.  However competition of IL-2 is 
only one proposed mechanism for Treg cells function. Treg cells that do not express 
CD25 are still able to efficiently suppress the proliferation of responder T cells (176).  
Therefore reduced expression of CD25 may have no effect on the function of Treg cells. 
GITR is constitutively expressed by Treg cells and recently activated T cells (177). The 
ligand of GITR is expressed on APCs and this constitutive expression of GITR by Treg 
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cells may allow Treg cells to bind APCs and interfere with T cell activation (139).  It has 
also been reported that Treg cell expansion occurs via the GITR receptor expressed on 
the surface of Treg cells (172). The higher expression of GITR is consistent with the 
delayed and decreased response of aged mice. If the T cell is impeded in its interaction 
with APCs, both a decrease can be envisioned. Taken together this may suggest that the 
early expression and binding of GITR to ligand interferes with T cell activation and 
results in the expansion of Treg cells and can lead to down regulation of the immune 
response in vivo.  
The ultimate goal of this project was to determine if the increased percentage of 
Treg cells in aged mice contributed to the decreased CD8 T cell response to influenza. To 
address this question we evaluated the in vivo kinetics of Treg cells following influenza 
infection in aged mice compared to young. We hypothesized that the increased 
percentage of Treg cells found at baseline in aged mice contributed to the delayed and 
decreased CD8 T cell expansion in function seen in aged mice after influenza infection.  
As demonstrated by Po et al. specific CD8 T cell expansion and function peaked 
early and higher in young compared to aged mice. Based on results obtained from in vitro 
experiments which demonstrated that following in vitro stimulation Treg cells percentage 
decreased, we anticipated that following influenza infection the percentage of Treg cells 
would be reduced to create space for CD8 T cell expansion. Several studies have 
demonstrated that prior to CD8 T cell expansion there is significant depletion of non-
specific CD8 T cells. These studies hypothesizes that “space” is needed for the expansion 
of specific CD8 T cells (100, 178). To our surprise following infection there was no 
decrease in the percentage of Treg cells in young or aged mice. In fact there was no 
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significant change in the percentage of Treg cells in young mice. In contrast, the 
percentage of Treg cells in aged mice continued to expand until CD8 T cell responses 
reached at peaked 10 days post infection. We propose that this increase in Treg cell 
percentage in aged mice contribute to the decrease and delay in CD8 T cell expansion 
and function. Similar to the removal of other non-specific T cells, removal of Treg cells 
must also occur to make room for specific CD8 T cell expansion in aged mice.  Further 
evaluation of Treg cells kinetics following influenza infection demonstrates that a 
significantly higher proportion of CD4+foxp3+ Treg cells in aged mice express elevated 
MFI and percentages of CD69.  We propose that this increased expression of CD69 may 
demonstrated increased activation and function of Treg cells in aged mice. Similar to 
Treg cell expansion, 10 days post infection Treg cells decrease the expression of CD69.  
Although there is no difference in the function of Treg cells isolated from young 
and aged mice, expansion of Treg cells early after infection may interfere with expansion 
and function of CD8 effector T cells. Our earlier results demonstrated that Treg cell 
suppression is dose dependent and in increasing numbers and percentages significantly 
suppresses the activation and expansion of effector T cells. These findings have been 
supported by others and demonstrated that increasing numbers of Treg cells can 
negatively impact the immune response to a foreign pathogen. 
 
Overall Conclusion 
Collectively we proposed that increased incidence of inflammation leads to 
increasing percentages and numbers of Treg cells in aged mice. Even in controlled 
systems such as animal facilities, aged mice can still have wounds and small infections. 
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This leads to small levels of immune activation and inflammation which stimulates the 
presence of increased percentages and numbers of Treg cells. These Treg cells can 
interfere with immunity to infectious pathogens.  
Based on the experiments performed in this project we propose that this increased 
percentage of Treg cells in aged mice raises the threshold of activation required for an 
adaptive immune response to infection. It has been postulated that a threshold of immune 
activation exists to protect the host from autoimmunity and assists in discriminating 
between self and non-self antigen (179). Grossman et al. hypothesize that immune 
response is a multistate system, which must balance maintenance, self-renewal and 
activation. Further Grossman and Paul hypothesized that re-occurent production of self-
antigen or immune responses that does not overcome the threshold of activation results in 
fine-tuning of this threshold thus increasing the amount of stimulation needed for an 
immune response to occur (180). We propose that increased percentages of Treg cells in 
aged mice coupled with expansion of Treg cells in vivo in response to influenza infection 
increases this threshold of activation and interferes with the specific CD8 T cell response 
to primary infection.  These increased percentages of Treg cells further reduce immunity 
in aged mice by contributing to an already age-altered immune response, demonstrated 
by reduced production of IL-2 as well as pro-inflammatory cytokines and reduced 
effector T cell differentiation, expansion and function.  
Growth cytokine IL-2 is necessary for the activation of the immune response. 
There are numerous studies dating since the 1980’s that stimulation of T cells from aged 
mice results in decreased production of IL-2 (181). Elrefaei et al. have more recently 
observed this age-associated decrease in IL-2 that following E55+MULV infection of 
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aged mice produce less IL-2 compared to young mice (51). While the decrease in IL-2 
may represent an intrinsic defect of T cells, the increased presence of Treg cells in aged 
mice may increase the amount of IL-2 needed for the expansion of effector T cells in 
aged mice, since the Treg cells were competing for IL-2.  
While the focus of our studies was CD4+foxp3+ Treg cells, our data suggest that 
CD69 may also be a regulatory component increased in aged mice. CD69 may actually 
be a regulatory marker, which can control the expansion and function of effector T cells. 
We demonstrated that as CD69 expression is reduced on CD4 and CD8 T cells they 
activate and expand more readily in young mice, whereas T cells from aged mice which 
express CD69 for much longer time periods have decreases in T cell expansion and 
activation.   
It has been demonstrated that while Th1 and Th2 differentiation is altered in aged 
mice, CD4 T cells in aged mice readily differentiate into Th17 cells (40). These Th17 
cells are believed to control the outcome of autoimmunity and have just been recently 
proven to be mutually exclusive from Treg cells (182).  Reduced production of IL-2 
results in the differentiation of CD4 T cells into Th17 cells (183). Further it has been 
demonstrated that TGF-β can induce the production of both Treg cells and Th17 cells 
(182). Although Treg cells and Th17 are two independent CD4 T cell subsets, the impact 
of Th17 differentiation on Treg cell development should be further evaluated, particularly 
since the reduced production of IL-2 in aged mice may further favor the induction of 
Th17 cells rather than Th1 and Th2 differentiation (40).  
Overall we propose that this increase in regulation ultimately raises the threshold 
of immune activation and interferes with CD 8 T cell responses (Figure 5.1).  
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 Figure 5.1 Threshold of activation in young and aged mice. Aged mice may need to 
make twice the amount of IL-2 in order to meet the threshold of activation due to 
increased percentages of Treg cells. Early competition for cytokines with T cells reduces 
expansion and activation, causing a delay in the aged immune response to influenza 
infection.  
 
 The results described in this thesis demonstrate that the increased proportion of 
Treg cells in aged mice contributes to the age-altered immune response. Reducing the 
number of Treg cells prior to infection could ultimately enhance the immune response of 
aged mice, and possibly even humans.  
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Future Direction 
1. Compare the function of Treg cells following influenza infection in vivo 
We demonstrated that following influenza infection Treg cells in aged 
mice expand and may interfere with the CD8 T cell response. The function 
of these expanded Treg cells should be compared with Treg cells from 
naïve aged mice to determine if the suppression is comparable to Treg 
cells prior to influenza infection. To perform these experiments Treg cells 
should be isolated from aged mice 7 days post infection and compared to 
Treg cells isolated from naïve aged mice and evaluated using an in vitro 
suppression assay. As described in this report, specific CD8 T cells should 
be isolated from TCR Tg mice, P14 or Cl-4 and used as the responder 
cells. In addition to evaluated the percentage of specific CD8 T cells, IFN-
g producing CD8 T cells and Treg cells, it may be helpful to also evaluate 
cytokine production. As several studies have demonstrated a role for TGF-
β and IL-10 in Treg cell function.  
 
2. Direct role of Treg cells in aged mice during influenza infection 
a. Compare the function of Treg cells in young and aged mice during 
influenza infection in vivo.  
This project compared the function of Treg cells from young and aged mice in 
vitro. It has been demonstrated by several studies that results obtained in vitro 
may not fully reflect their function in vivo. To this end it may be necessary for the 
function of Treg cells from young and aged mice to be compared in vivo. For 
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these studies Treg cells should be isolated from young and aged mice and 
adoptively transfer into young mice. In addition we also hypothesized that the 
environment of aged may be altered so both young and aged mice should be used 
as recipients (Figure 5.2). 7 days post-infection mice should be evaluated for CD8 
T cell expansion and function, along with Treg cell percentages, to determine if 
addition of Treg cells alters CD8 T cell or Treg cell kinetics and also to determine 
if there is a difference in the suppressive abilities of Tregs from young and aged 
mice.  
 
 
Figure 5.2 Comparison of Treg cell function in vivo, Experimental Design. 
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b. Determine if depletion of Treg cells using PC61 restores the specific 
CD8 T cell response in aged mice.  
The removal of Treg cells from aged mice will allow use to 
determine if CD8 T cell expansion and function is increased in their 
absence. PC-61 has been shown to bind to the IL-2Rα and interfere with 
IL-2 binding (184). This antibody is often used as a way to selectively 
depleted CD4+CD25+ Treg cells in mice, however the drawback to using 
PC-61 is that in excess amounts it can also bind to recently activated T 
cells and reduce their expansion and activation. Further we have 
demonstrated that a large proportion of Treg cells in aged mice do not 
expressed CD25, demonstrated by elevated percentages of CD4+foxp3+ T 
cells compared to CD4+CD25+ cells in aged mice (Figure 4.3). Further it 
has been demonstrated that following PC-61 treatment CD25+ Treg cells 
are rapidly regenerated (185). These limitations make these experiments 
very difficult to control. However Lahl et al. has a established a 
conditional knock-out mice which express diphtheria toxin (DT) receptor–
enhanced green fluorescent protein fusion protein under the control of the 
foxp3 gene locus, which allows for the selective knock-down of Treg cells 
using diphtheria (84). Similar protocols have been established for the 
conditional removal of other immune cells (27). If one could obtain these 
mice an experiments studying the kinetics of CD8 T cells in the absence of 
Treg cells is possible.  
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Chapter Six: 
Appendix I: Regulatory T Cell Kinetics in Aged Balb/c Mice Following Influenza 
Infection 
Yolanda Williams-Bey and Donna M. Murasko 
 Abstract 
 Several studies demonstrate that aged mice have an increased percentage of Treg 
cells compared to young mice. Further it has been demonstrated that the percentage and 
number of Treg cells is dependent not only on the age of mice but the genetic background 
as well. Based on this and other documented differences in the immune response of mice 
of different genetic backgrounds, we wanted to determine if the expansion of Treg cells 
following influenza infection could be demonstrated in another strain of mice. We 
demonstrate here that similar to infection in aged C57BL/6 mice, Treg cells expand in 
aged Balb/c mice following in vivo influenza infection.  
 
Introduction 
 The increased incidence of infectious diseases in the elderly population is 
believed to be due, in part, to a compromised immune system. The age-associated decline 
in the immune response has been demonstrated in both humans and mice, most notably as 
diminished T cell activation and proliferation (147).  
It is widely accepted that the immune response has a genetic component, which 
controls the outcome of infection and disease (186). Inbreeding of mice allows us to limit 
the range of genetic factors and reduce variability. Since genetic variations in the immune 
response of humans will always exist, it is necessary to ensure that differences in aging 
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immunity found in mice was a general phenoma and therefore needed to be assessed 
across various mice strains.  
C57BL/6 and Balb/c mice are excellent models for evaluating the differences in 
aging immunity across different genetic strain (187), as these two strains have been 
demonstrated to have the most divergent response in their immune response to pathogen, 
due to genetics (188). Specifically while Balb/c mice appear to have an immune response 
geared towards a Th2 Ab response and are efficient at producing high amounts of 
antibody to fight off extracellular pathogen, their ability to respond to intracellular 
pathogen is reduced compared to C57BL/6 mice (187, 189, 190). The opposite is the case 
for C57BL/6 mice: these mice have a response geared towards a Th1 response and have a 
robust cell-mediated response, which leads to efficient removal of intracellular pathogens 
(187, 189, 190). These differences in immunity allow us to evaluate whether changes in 
the aged immune response are consistent with respect to genetic background.  
In addition to the increased number and percentage of Treg cells found in aging, 
recently it has been demonstrated that there is also a difference in Treg cells based on 
genetics. Specifically Chen et al. demonstrate that Balb/c mice have an increased number 
and percentage of Treg cells compared to C57BL/6 (171). They also demonstrated that 
the T cells of Balb/c mice are more vulnerable to suppression by Treg cells than T cells 
isolated from C57BL/6 mice (171). 
We wanted to expand on results found in C57BL/6 mice to determine if the same 
phenomena are seen using Balb/c mice. Specifically we want to determine if following 
influenza infection the percentage of Treg cells expand in aged but not young mice. 
These experiments will determine whether or not the expansion of Treg cells in aged 
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mice following acute influenza infection is strain specific or a phenomenon seen in 
several genetically different mice strains.  
Results and Discussion 
Evaluation of Treg cells percentage and function in young and aged C57BL/6 mice 
 The percentage of Treg cells was assessed at baseline in young and aged mice. As 
reported in other studies, the percentage of Treg cells was significantly increased in aged 
Balb/c mice compared to their younger counterparts (135). Comparing the percentage of 
CD4+CD25+ (young vs aged, 12.0 ± 1.1 vs 18.8 ± 1.4, respectively p<0.001) CD4+foxp3+ 
(young vs aged, 15.2 ± 0.7 vs 23.4 ± 1.5, respectively p<0.001) or 
CD4+CD25+foxp3+(young vs aged, 13.5 ± 0.9 vs 19.9 ± 1.9, respectively p<0.001) Treg 
cells, we demonstrate that similar to C57BL/6 mice the percentage of Treg cells in aged 
mice is significantly increased compared to young mice.  
 A Suppression assay was used to compare the in vitro function of Treg cells from 
young compared to aged mice. We evaluated the ability of Treg cells from young and 
aged Balb/c mice to suppress TCR specific Tg CD8 T cells from HA Cl-4 mice as 
described in Chapter 4. The results from this experiment demonstrate that Treg cells from 
young and aged mice suppress specific CD8 T cells at similar levels (Figure 6.1A-C). 
Further a significant inverse correlation exists between the percentage of CD4+foxp3+ T 
cells and CD8 T cell activation in cell cultures 72 hours post-stimulation (Figure 6.1D).  
Collectively these results demonstrate that the increase percentage of Treg cells in 
aged mice is not a strain dependent phenomenon. Further the intrinsic function of Treg 
cells from aged Balb/c mice does not seem to be altered compared to Treg cells from 
young mice.  
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Regulatory T cell kinetics in young and aged Balb/c mice following influenza infection 
The kinetics of Treg cells following influenza infection were evaluated in young 
and aged Balb/c mice. The results from two experiments were inconsistent, as early 
studies demonstrated that following influenza infection in aged Balb/c mice the 
percentage of Treg cells is significantly increased 7 days post infection (Figure 6.2A), 
while a later experiment demonstrated that there was an increase in Treg cells following 
infection aged mice however this change was not significant (Figure 6.2B). We also 
found that the CD8 T cell responses, both expansion and IFN-γ production are decreased 
in Balb/c mice compared to C57BL/6 mice in both young and aged (19). It is possible 
that the smaller response seen in Balb/c mice limits the ability to obtain statistically 
significant differences in Treg cells. 
 These results collectively demonstrate in different mice strains C57BL/6 and 
Balb/c that Treg cell function in vitro is similar and also that following influenza 
infection the percentage of Treg cells expand in young but not aged mice. Further 
experiments should be performed to solidify the amount of Treg cell expansion in age 
Balbc mice following influenza infection.  
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Figure and Legends 
 
 
Figure 6.1. Treg cell suppression. Young and aged isolated Treg cells suppress Tg 
splenocytes at similar levels. CD4+CD25+ Treg cells were isolated from young and aged 
WT B6 mice and co-cultured at a ratio of 1:1 or 1:10 (Tg splenocyte:Treg cell). A) 
Histogram representation of Tg splenocytes stimulated in the absence and presence of 
young or aged enriched CD4+CD25+ cells. B) Percent CD8 T cell expansion and C) 
activation. D) Correlation between CD4+foxp3+ Treg cells  and activated CD8+CD25+ T 
cell. Data represents the mean ± S.E., n=3. Similar results were obtained in two 
experiments.  
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Figure 6.2. Kinetics of Treg cells in aged mice following influenza infection. 
Characterization of CD4 T cells in the spleens of young and aged mice. Splenocytes were 
isolated from young and aged C57BL/6 mice then stained with antibodies associated with 
Treg cells (CD4, CD25 and foxp3) and assessed by flow cytometry. A) Experiment 1. B) 
Experiment 2. Values represent the mean ± S.E., n=7 - 30 mice per group. *p<0.05, 
**p<0.01, ***p<0.001.  
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Chapter Seven: 
Appendix II: Adoptive Transfer of Treg Cells into Young Mice Reduce the Function 
of CD8 T Cells 
Yolanda Williams-Bey and Donna M. Murasko 
 Abstract 
 Several studies demonstrate that aged mice have an increased percentage of Treg 
cells compared to young mice. Further it has been reported that aged mice have a reduced 
CD8 T cell response to influenza infection. No study has directly determined if this 
increased Treg cell percentage and number contributes to the reduced CD8 T cell 
response seen in aging during influenza infection. In these studies we report that the 
adoptive transfer of Treg cells into young recipient mice reduces IFN-γ production by 
CD8 T cells. We also demonstrate that adoptive transfer of Treg cells does not affect 
specific CD8 T cell expansion nor does it increases the severity of infection. Taken 
together these results demonstrate a role for Treg cells in the suppression of CD8 T cell 
function in aged mice during influenza infection.  
 
Introduction 
Regulatory T cells (Treg cells) have been shown to negatively impact the immune 
response to infection. It has been demonstrated that Treg cells protect the host from 
autoimmunity, however in increasing numbers and percentages these cells have been 
shown to reduce both anti-tumor and anti-viral responses. It has been reported that Treg 
cell number and percentage is increased in cancer patients (191). Also Zelinskyy et al. 
demonstrated that following chronic friend retrovirus infection the percentage of Treg 
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cells is increased and interferes with CD8 T cell expansion (192). Further it has been 
demonstrated that the rate of survival following both tumor inoculation and infection is 
directly proportional to the number of Treg cells (133, 191, 192). Recently Suvas et al. 
reported that the adoptive transfer of CD4+CD25+ Treg cells reduces the expansion and 
function of CD 8 T cells during herpes simplex virus-2 (HSV-2)(166).  
Collectively these studies demonstrated that Treg cells down-modulates CD8 
specific CD8 T cells. In these studies we want to directly address whether or not 
increased Treg cell numbers can induce a delayed or decreased CD8 T cell response in 
young mice that is seen in aged mice. We demonstrate that the adoptive transfer of Treg 
cells into mice prior to influenza infection reduces IFN-γ production by CD8 T cells.  
Results and Discussion  
 We previously reported that specific CD8 T cell responses in aged mice are 
altered, demonstrated by decreased and delayed specific CD8 T cell expansion as well as 
specific CD8 T cell function, assessed by IFN-γ production (61). We hypothesized that 
this decreased CD8 T cell expansion and function may be linked to the increase 
percentage of Treg cells seen in aged mice. Studies have demonstrated that increased 
percentages and numbers of Treg cells decreased the immune response (193, 194). To 
test this hypothesis Treg cells were adoptively transferred into recipient young mice to 
determine if CD 8 T cell expansion and function would be reduced.  
 The results from this experiment demonstrate that adoptive transfer of 2.3x104 
Treg cells prior to infection have minimum effect on severity of infection, demonstrated 
by weight loss (Figure 7.1A) as well as CD8 T cell expansion (Figure 7.1B). While no 
difference was demonstrated in severity of infection and specific CD8 T cell expansion, 
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the production of IFN-γ by CD8 T cells was reduced, although not significant (Figure 
7.1C). Tg splenocytes were isolated from Cl-4 mice, while CD4+CD25+ Treg cells were 
isolated from uninfected young (2-8 months) donor Balb/c mice and co-transferred into 
young recipient mice prior to infection. Recipient mice were then inoculated with 300 
H.A.U. PR8 influenza virus, four hours after co-transfer. All mice were sacrificed 4 days 
post infection, and splenocytes were stained with antibodies that recognize CD8, HA518-
526, CD44 and IFN-γ to evaluate CD8 T cell expansion and function. The results support 
the earlier findings that Treg cells reduce CD8 T cell function, specifically when Treg 
cells are co-transferred with CD8 T cells IFN-γ production is reduced. The adoptive 
transfer of only 1.2x104 Tg cells , resulted in 3.1% CD8 T cells producing IFN-γ were as 
co-transfer of 1.2x104 Tg cells with 3x104 Treg cells resulted in only2.4% of CD8 T cells 
secreting IFN-γ. 
 We report here that small numbers of Treg cells have an effect on CD8 T cell 
function during influenza infection. Following adoptive transfer of Treg cells into 
recipient mice there was a decrease in IFN-γ production by CD 8 T cell. However there 
was no change in specific CD8 T cell expansion or severity of infection. We propose that 
this was because only small numbers of Treg cells were adoptively transferred in young 
Balb/c mice. In intact mice there are 7.3x105 CD4+CD25+ cells in young mice versus 
1.0x106 CD4+CD25+ in aged mice. We only transferred 2.4x104-4.3x104 cells. We 
propose that if the dosage of Treg cells being adoptively transferred were increased to at 
least 1x106 for each recipient mouse, we would see drastic changes in CD8 T cell 
function and CD8 T cell expansion. These results agree with studies performed by Suvas 
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et al. (166) demonstrating that Treg cells decrease the CD8 T cell response during 
infection.  
 These results demonstrate the direct involvement of increased Treg cells in the 
decreased CD8 T cell function. We propose that if slight numbers of Treg cells can affect 
CD8 T cell function, then the increase number of Treg cells seen in aged mice which is ≥ 
3x105 can make a significant impact of CD8 T cell function.     
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Figure and Legends 
 
Figure 7.1. Adoptive transfer of Regulatory T cells prior to influenza infection. A) 
Percent weight loss was calculated at 1,2,3,4,5 and 7 and compared to baseline weights.  
B) CD8 T cell expansion in PR8 only and PR8 with Treg cells. C) CD8 T cell function in 
with and without Treg cells. Values represent the mean ± S.E., n=3. Similar results were 
obtained in two experiments.  
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